The QualityStocks Daily Wednesday, July 15th, 2020

Today's Top 3 Investment Newsletters

QualityStocks (AXIM) +204.49%

MarketClub Analysis (GENE) +150.88%

OTCtipReporter (JRJC) +93.30%

The QualityStocks Daily Stock List

Acquired Sales Corp. (AQSP)

Market Screener, Real Investment Advice, Wallet Investor, Barchart, Wall Street Analyzer, Market Exclusive, Street Insider, Central Charts, Nasdaq, 4-Traders, Simply Wall St, GlobeNewswire, InvestorsHub, Investors Hangout, last10k, Stockhouse, Dividend Investor, YCharts, MarketBeat, Seeking Alpha, GuruFocus, Dividend.com, Wallmine, Morningstar, Green Market Report, Business Wire, Marijuana Stock Review, and MarketWatch reported previously on Acquired Sales Corp. (AQSP), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Acquired Sales Corp. is a consolidator of companies making branded cannabinoid-infused products. These products include beverages, muscle/joint rubs, oils, crystals, tinctures, bath bombs, and isolate. Products also include relief balms, elixirs, body washes, med sticks, lotions, vape pens and cartridges, shatter, as well as gummies. On February 24, 2020, the Company acquired 100 percent of fast growing and profitable Warrender Enterprise, Inc. d/b/a Lifted Made (previously d/b/a Liquids), of Zion, Illinois. Acquired Sales has its head office in Lake Forest, Illinois. The Company’s shares trade on the OTC Markets.

Acquired Sales believes in the value of cannabinoids (CBD, CBG, CBN, etc.). In addition, the Company owns 4.99 percent of CBD-infused beverage and products maker Ablis Holding Company, and of craft distillers Bendistillery, Inc. d/b/a Crater Lake Spirits and Bend Spirits, Inc., Bend, Oregon, that it purchased on April 30, 2019 for $1,896,200 in cash.

The Company’s House Brands include Lifted Made. This is the distinguished house of creative cannabis products targeting astute consumers who demand the highest quality products, fast delivery systems, and lasting effects.

Furthermore, House Brands include Levé-Pâte De Fruit. Levé is a cannabis-infused confectionary brand, focused around the highest quality vegan ingredients imported from France. Another House Brand is Urb-Finest Flower. Urb is an exclusive cannabis hemp flower brand. Urb is focused around supporting American farmers, using rare hemp genetics (strains) paired with one-of-a-kind packaging.

This past March, Lifted Made, a wholly owned subsidiary of Acquired Sales Corp. announced that it signed an exclusive agreement to manufacture CBD-infused products for American Top Team, the leader in MMA (mixed martial arts) and Brazilian jiu-jitsu training. American Top Team is globally renowned for its MMA pro team and kids training camps. It was founded by Mr. Dan Lambert in 2001 and is based in Coconut Creek, Florida.

Acquired Sales Corp. (AQSP), closed Wednesday's trading session at $1.66, off by 2.3529%, on 100 volume with 1 trade. The average volume for the last 3 months is 258 and the stock's 52-week low/high is $1.25/$9.14999961.

chart

Bionik Laboratories Corp. (BNKL)

Zacks, Corporate Information, PR Newswire, Whale Wisdom, OTC Markets, Wallet Investor, last10k, The Street, Seeking Alpha, Proactive Investors, Research and Markets, MarketWatch, Barchart, Business Wire, Stockhouse, CSI Market, Emerging Growth, Stockopedia, and InvestorsHub reported beforehand on Bionik Laboratories Corp. (BNKL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bionik Laboratories Corp. focuses on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home. A robotics business, the Company has three products on the market and three products in different stages of development. These products focus on upper and lower extremity rehabilitation for stroke and other mobility-impaired patients. OTCQB-listed, Bionik Laboratories is based in Toronto, Ontario. The Company has its U.S. headquarters in Watertown, Massachusetts.

The Company’s set of robotic rehabilitation products are the result of leading-edge medical engineering research and development (R&D) at the Newman Laboratory for Biomechanics and Human Rehabilitation at the Massachusetts Institute of Technology (MIT). Bionik’s products include InMotion ARM ™; InMotion HAND™, and InMotion WRIST™. InMotionRobots™ are for all stages of recovery – from acute to chronic. Bionik Laboratories has its newest generation InMotion ARM/HAND™ robotic system for clinical rehabilitation of stroke survivors and those with mobility impairments because of neurological conditions. The design of its modular systems approach to neurorehabilitation is to optimize the use of robotics in a manner consistent with the most modern clinical research and neuroscience. This is while considering the latest understanding on motor learning interference and motor memory consolidation.

Bionik’s robotic products have first-rate capacity for measurement and immediate interactive response. These products sense the patient’s movement and respond to a patient’s continually-changing ability. Furthermore, robots guide the exercise treatment accordingly and provide quantifiable feedback on progress and performance. Additionally, if the patient cannot move, the robot gently assists the patient to initiate movement towards the target.

Last month, BIONIK Laboratories announced it launched its InMotion Connect™ platform. This is a comprehensive solution to meet the data connectivity and analytics needs of hospitals and healthcare facilities throughout the nation.

InMotion Connect™ is a cloud-based data analytics solution. It securely streams and stores anonymized data from all connected InMotion® robotics devices to the Company’s cloud server hosted by Amazon AWS, providing contextual and relevant data to reach hospital clinicians and management teams when it matters the most. InMotion Connect™ combines real-time data of each InMotion® robotic device with the deep clinical knowledge and expertise of Bionik’s clinical specialists to collaboratively partner with each clinic to promote utilization of the robotic devices and support clinician engagement, with the aim of enhancing patient care.

Bionik Laboratories Corp. (BNKL), closed Wednesday's trading session at $1.80, even for the day, on 2,093 volume. The average volume for the last 3 months is 703 and the stock's 52-week low/high is $0.990000009/$7.00.

chart
n

HempAmericana, Inc. (HMPQ)

The Wolf of Penny Stocks, Central Charts, MicroSmallCap, Stock Day Media, Stockhouse, Beat Penny Stocks, Simply Wall St, TradeKing, GlobeNewswire, Stock of the Week, InvestorsHub, Investing.com, MMJ Reporter, Epic Stock Picks, OTC Dynamics, Baystreet.ca, TMXmoney, and Stockwatch reported earlier on HempAmericana, Inc. (HMPQ), and today we report on the Company, here at the QualityStocks Daily Newsletter.

HempAmericana, Inc. researches, develops, and sells products made of industrial hemp in the United States. The Company is an emerging participant in the CBD (cannabidiol) products market. It owns and operates a high-capacity, state-of-the-art CBD extraction and processing facility in Augusta, Maine. Established in 2014, HempAmericana is based in New York City and lists on the OTC Markets.

HempAmericana’s extraction and processing facility has a supersized, supercritical CO2 extraction system, centrifugal partition chromatography refinement technology, and a mechanized fully-automated CBD bottling system. Furthermore, the Company researches, develops, and sells products made of industrial hemp. This includes a popular brand of hemp rolling papers marketed under the brand name, “Rolling Thunders”.

HempAmericana’s CBD oil business uses the brand designation, "Weed Got Oil". The Company continues to pursue an active place in the CBD white label market segment. This is chiefly for those companies looking for premium full-spectrum distillate CBD oil.

HempAmericana has purchased a 100-liter solvent recovery system, the Ecochyll X7 High Speed Evaporator. This system represents a 400 percent increase in evaporative capacity for the Company’s production line technology. This past May, HempAmericana announced the upcoming launch of its new Cannabigerol (CBG) oil product. This product is currently being laboratory tested for purity and potency. The product will be available for purchase on HempAmericana’s recently launched e-commerce portal (HempAmericana.store) and also through its newly established distribution relationship with the Alibaba B2B platform.

Cannabigerol (CBG) is a cannabinoid found in cannabis. Like CBD, CBG is non-intoxicating. Moreover, it has been shown to bind to receptors in the body's natural endocannabinoid system (ECS), which functions to help regulate a broad array of physiological functions and systems, including different cardiovascular, nervous, and immune system functions inside cells, according to research published by the National Institutes of Health (NIH). HempAmericana sees this new product as complementary to its existing line of cannabinoid-based products.

HempAmericana, Inc. (HMPQ), closed Wednesday's trading session at $0.002, off by 7.8341%, on 943,055 volume with 33 trades. The average volume for the last 3 months is 4,132,235 and the stock's 52-week low/high is $0.001/$0.0086.

chart

HIVE Blockchain Technologies Ltd. (HVBTF)

Blockchain Stocks, Wallmine, Stockhouse, Equities.com, Micro Small Cap, TipRanks, Investors Hangout, GuruFocus, FXStreet, Smarter Analyst, Crypto141, 4-Traders, Market Screener, InvestorsHub, Dividend Investor, Simply Wall St, YCharts, Trading View, Insider Financial, Invest Tribune, Stocktwits, and Stockwatch reported previously on HIVE Blockchain Technologies Ltd. (HVBTF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQX-listed, HIVE Blockchain Technologies Ltd. is a company building a bridge from the blockchain sector to traditional capital markets. It is strategically partnered with Genesis Mining Ltd. to build the next generation of blockchain infrastructure. The Company’s mission is to hasten the development of the blockchain sector via traditional capital markets and create long-term shareholder value. Its deployments provide shareholders with exposure to the operating margins of digital currency mining and a growing portfolio of crypto-coins.

HIVE Blockchain Technologies owns state-of-the-art GPU-based digital currency mining facilities in Iceland and Sweden that produce newly minted digital currencies such as Ethereum continuously and also a cloud-based ASIC-based capacity that produces newly minted digital currencies including Bitcoin. HIVE has an exclusive arrangement with Genesis Mining to operate its data centers under a Master Service Agreement. The data centers will be monitored with Genesis Hive, which is Genesis Mining's proprietary software tool for large-scale mining, to automatically optimize chip temperatures and power consumption for maximal coin production.

Concerning the Iceland Cryptocurrency Mining Project, HIVE’s launch transaction involved the acquisition of an initial state-of-the-art blockchain infrastructure facility in Iceland from Genesis Mining. The facility produces mined cryptocurrency around the clock. Assembly of the facility, which uses innovative computing components and infrastructure design, was completed in May of 2017. In Sweden, HIVE's GPU facilities were completed in April of 2018. They are equipped with custom Genesis A2 mining rigs. In November of 2019, HIVE announced that it completed the transition of its GPU chips in Sweden to Blockbase Group DWC-LLC from Genesis Mining, pursuant to HIVE’s strategic partnership with Blockbase signed in August of 2019.

This month, HIVE Blockchain Technologies announced that it ordered 200 Bitmain Antminer S17e 60 Terahash per second (TH/s) SHA 256 mining machines as the Company continues to scale up next generation mining power at its green energy-powered bitcoin mining operation in the Province of Quebec. The cost for the S17e machines was roughly US$950 per unit, or just under US$0.2 million, financed through HIVE’s cash. Delivery and installation of the new mining equipment is anticipated to take place this month.

HIVE Blockchain Technologies Ltd. (HVBTF), closed Wednesday's trading session at $0.243, off by 2.80%, on 706,201 volume with 140 trades. The average volume for the last 3 months is 1,005,749 and the stock's 52-week low/high is $0.058499999/$0.409900009.

chart

Kisses from Italy, Inc. (KITL)

Stockhouse, Stockwatch, GlobeNewswire, OTC Markets, Market Screener, One News Page, Baystreet.ca, Business Insider, Morningstar, GuruFocus, Stockopedia, FastCasual.com, CRWE World, Nasdaq, Tiingo, last10k, Dividend.com, TradingView, getfilings.com, Simply Wall St, and OTC.Watch reported beforehand on Kisses from Italy, Inc. (KITL), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Kisses from Italy, Inc. focuses on developing a fast and casual food dining chain restaurant business in the United States. Additionally, the OTCQB-listed Company franchises its restaurants. Its mission is to provide the highest level of service, and high quality ingredients and products. This is while bringing ‘Traditional Italian Delicacies with an All-American Flair’ to life, worldwide. Incorporated in 2013, Kisses from Italy is based in Miami, Florida.

Currently, the Company operates four corporate owned stores. It concentrates on fast-casual dining with traditional Italian Panini, homemade lasagna, salads, panzerotti di Bari, Italian coffee, dessert, and breakfast offerings. Kisses from Italy successfully began operations in May of 2015 with the opening of its flagship location in Ft. Lauderdale at 3146 NE 9th St. This was followed by three additional sites across the greater Ft. Lauderdale/Pompano Beach area. The Company opened its inaugural European location in Ceglie del Campo, Bari, Italy in October of 2019.

The Company focuses on supporting and partnering with local producers and suppliers within the regions. This is to provide a truly authentic experience to its customers. Kisses from Italy’s goal is to introduce the fresh, savory, and rustic taste of Italian delicacies into the fast paced worldwide society.

Furthermore, the Company’s vision is to leverage the success from its flagship store and its initial hotel locations in the South Florida market and to expand into other regions on a local, State, national and international level. The chief focus is doing this through its continued corporate owned store expansion, along with the development and sales of additional locations through the advancement of its franchise and territorial rights program.

In June, Kisses from Italy announced, that following the recent opening of Kisses From Italy's European location in Italy, and with its first Franchise Agreement for the California now complete, the Kisses from Italy restaurant group continues its expansion plans with the signing of a Multi-Unit Development Agreement for 100 locations in Canada.

Michele Di Turi, a Co-founder, President and Co-Chief Executive Officer of Kisses From Italy, said, "We believe there is a huge potential for a brand like Kisses From Italy to be established and scaled throughout Canada. We are confident that Canada will play a pivotal position in the implementation and growth of our international distribution plan. With the new deal in place for Canada, we expect to see the immediate development of Kisses From Italy restaurants across the country."

Kisses from Italy, Inc. (KITL), closed Wednesday's trading session at $0.10, even for the day, on 300 volume. The average volume for the last 3 months is 1,277 and the stock's 52-week low/high is $0.07/$0.300000011.

chart

Minera Alamos, Inc. (MAIFF)

Gold Stock Data, StreetWise Reports, Proactive Investors, Wallet Investor, Mexico Mining Center, YCharts, Newsfilecorp, Stockwatch, 4-Traders, InvestorX, Stockhouse, PR Newswire, 24hgold, Business Insider, Proven and Probable, Geology for Investors, GuruFocus, GlobeNewswire, and Northern Miner reported earlier on Minera Alamos, Inc. (MAIFF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Minera Alamos, Inc. engages in the acquisition, exploration, and development of mineral properties in Mexico. The Company has a growing portfolio of high-quality Mexican assets. This includes the La Fortuna open pit gold project in Durango and the Santana open pit heap-leach development project in Sonora. An advanced-stage exploration and development company, Minera Alamos is headquartered in Toronto, Ontario. The Company was previously known as Virgin Metals, Inc. It changed its name to Minera Alamos, Inc. in May of 2014. Minera Alamos’ shares trade on the OTCQB.

The Company’s strategy is to develop low capex (capital expenditure), high margin assets with expansion opportunities. This is while continuing to pursue complementary strategic acquisitions. The La Fortuna open pit gold project in Durango has a positive PEA completed (permits granted). The La Fortuna project is 6,200 ha. Minera Alamos acquired 100 percent of the 4 mining concessions that comprise the La Fortuna project in May of 2016 from Argonaut Gold, Inc. The concessions are subject to a 2.5 percent NSR (Net Smelter Return) on production to a maximum of US$4.5M payable to Argonaut Gold.

The Santana open pit heap-leach development project in Sonora has test mining and processing completed (permits pending). The Santana project is 8,500 ha. It is strategically located in a rich mining district. The district features operational mines from some of the globe’s leading names in precious metals mining (Goldcorp, Agnico Eagle, Alamos Gold).

Today, Minera Alamos provide a mid-year construction update detailing progress at the Santana gold project, Sonora, Mexico. The heap leach pad area has been cleared of all vegetation. It is undergoing contouring ahead of clay placement and the pad liner installation.

The completed explosive storage & detonator bunkers are awaiting final inspection from the Mexican authorities ahead of the explosive permit issuance. In addition, bypass road construction at either end of the heap leach pad area is taking place.

Fabrication of the plant carbon columns is complete. Work is underway for the remaining plant steel structures. Furthermore, the earthworks contractor chosen has worked previously with the Minera Alamos team when they were building the El Castillo mine in Durango.

Minera Alamos, Inc. (MAIFF), closed Wednesday's trading session at $0.409, up 2.7638%, on 189,395 volume with 62 trades. The average volume for the last 3 months is 364,371 and the stock's 52-week low/high is $0.097000002/$0.43900001.

chart

WeedMD, Inc. (WDDMF)

NetworkNewsWire, Financial Insiders, Micro Small Cap, Midas Letter, Street Insider, Fortune420, The Cannabis Investor, Profit Confidential, Investor Ideas, New Cannabis Ventures, Financial Buzz, Stockwatch, Morningstar, Daily Marijuana Observer, Greenshoe Media Group, Stock Day Media, GuruFocus, OTC Markets, NIC Investors, Marijuana Stock Review, CannabisMarketCap, Pot Stock News, Micro Small Cap, and Wallmine reported earlier on WeedMD, Inc. (WDDMF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQX-listed, WeedMD, Inc. is a federally-licensed producer and distributor of medical-grade cannabis. The Company is the publicly-traded parent company of WeedMD RX, Inc. and Starseed Medicinal, Inc., federally-licensed producers of cannabis products for the medical and adult-use markets. WeedMD has a multi-channeled distribution strategy. This includes selling directly to medical patients, strategic relationships across the seniors’ market, and supply agreements with Shoppers Drug Mart and six provincial distribution agencies where adult-use brands Color Cannabis and Saturday are sold. WeedMD is based in Aylmer, Ontario.

The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor, and processing facility in Strathroy, Ontario and also CX Industries, Inc., a wholly-owned subsidiary that specializes in cannabis extraction from the Company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario processing facility. With the addition of the Starseed Medicinal, WeedMD has expanded its multi-channeled distribution strategy. Starseed is a medical-centric operator based in Bowmanville, Ontario. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with other employers and union groups complements WeedMD’s direct sales to medical patients.

WeedMD has its Color™ Cannabis. Color Cannabis was developed specifically for a diverse adult-use market that reflects the range in tastes and preferences of contemporary cannabis consumers. Color Cannabis products include an assortment of strains, in manifold formats, developed with premier quality cannabis. Color Cannabis is a first-rate brand exclusively available to distributors and select retailers across Canada.

WeedMD has started preparations for its 2020 outdoor growing season, making this WeedMD’s second season cultivating outdoors. It will be growing cannabis on its 27-acre fully-licensed outdoor field in Strathroy, Ontario. Clones were planted in early June and will harvested throughout the fall of 2020.

In June, WeedMD announced the launch of its unique line of strain-specific medicinal vaporizer pens (vapes). The ‘Aurum’ vapes are available to Starseed patients across Canada as part of WeedMD’s expanding medical cannabis product portfolio as an insured benefit. The Company’s medical vaporization product line will be available to medical patients in the coming weeks. It will expand into the adult-use market under its Color Cannabis brand in Q3 of 2020.

WeedMD, Inc. (WDDMF), closed Wednesday's trading session at $0.311825, off by 5.8215%, on 416,123 volume with 187 trades. The average volume for the last 3 months is 114,476 and the stock's 52-week low/high is $0.178299993/$1.37999999.

chart

Peeks Social Ltd. (PKSLF)

Capital Cube, Stock Pulse, Stockwatch, Stockhouse, GlobeNewswire, StockInvest.us, Stock Day Media, Cantech Letter, InvestorX, TeleTrader, GuruFocus, OTC Markets, Market Screener, Global Banking and Finance, Mobile Marketer, Wallet Investor, TradingView, Seeking Alpha, TMXmoney, Nasdaq, MarketWatch, InvestorsHub, Simply Wall St and Dividend.com reported beforehand on Peeks Social Ltd. (PKSLF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Peeks Social Ltd. engages in the development and marketing of mobile video and livestreaming social media products. The Company does so under the Peeks Social brand for consumers and businesses in Canada. Peeks Social is based in Toronto, Ontario. It operates in Canada, the United States, Africa, the Middle East, India, Europe, and internationally. The Company lists on the OTC Markets Group’s OTCQB.

Peeks Social is a live streaming platform. A user can ‘go live’ and begin broadcasting their stream from anywhere to anyone globally. A user can grow their followers overnight by getting featured in Peeks Social. Furthermore, they can explore by watching exclusive live streams and videos from around the world and also receive special offers.

A user can become a broadcaster through downloading the Peeks Social App and start broadcasting. They can become a Peeks Social Influencer. One can join the Peeks Social Influencer program and increase their star power. Additionally, they can get special deals and earn more coins.

A user can also earn money with Peeks Social through getting sponsored. A user can get automatically paired with an advertising partner based on the keywords in their stream title and earn money for each interaction.

In February, Peeks Social announced that further to its press release dated February 13, 2020, there was an error in the number of units being issued to Mr. Mark Itwaru, Chief Executive Officer of the Company. The number was reported as 41,141,340 and should have been 39,141,340.

On February 13, 2020, it was announced that an additional $310,000 of financing had been further arranged to the Company’s January 13, 2020 announcement pertaining to a non-brokered private placement. Management and Insiders have subscribed for $300,000 of the total amount of this second $310,000 tranche.

$200,000 of the final tranche was being contributed by Chief Marketing Officer Mr. Rick Padulo and an additional $100,000 from Mr. Itwaru was contributed on top of Mr. Itwaru’s earlier announced $1,857,067 from January 13, 2020 for a total of $1,957,067. In total, Peeks Social issued an aggregate of 39,141,340 units at a price of $0.05 per units to Mark Itwaru, for gross proceeds of $1,957,067. The private placement proceeds will be used for ongoing for general corporate purposes.

Peeks Social Ltd. (PKSLF), closed Wednesday's trading session at $0.048, up 47.6923%, on 100 volume with 1 trade. The average volume for the last 3 months is 4,490 and the stock's 52-week low/high is $0.0031/$0.090899996.

chart

DXI Energy, Inc. (DXIEF)

Stockfuse, MarketWatch, InvestorsHub, Zacks, Oilandgas360, Tip Ranks, Wallet Investor, Stock Digest, Amigo Bulls, Dividend Investor, Stockhouse, Private Capital News Wire, Stockwatch, Equity Clock, The Street, Barchart, Marketwired, YCharts, Capital Cube, Street Insider, Marketbeat, ValueForum, and Seeking Alpha reported on DXI Energy, Inc. (DXIEF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter. 

DXI Energy, Inc. is a tactical acquisitor and developer of strategic energy resources. The Company is an upstream oil and gas exploration and production company. DXI Energy operates in Colorado’s Piceance Basin and in the Peace River Arch area in British Columbia  (B.C.). DXI Energy has offices in Calgary, Alberta, and Vancouver, British Columbia. The Company’s shares trade on the OTC Markets’ OTCQB.

In Colorado’s Piceance Basin, DXI Energy has 24,407 net acres.  In the Peace River Arch area in B.C. it has 13,093 net acres. Concerning its project areas, in the Piceance Basin in northwest Colorado, DXI has its Kokopelli project with 12 producing wells with extensive in place infrastructure to supplement future development as product prices dictate. 

The Company’s land holdings in the Piceance Basin highlight potential long-term regional resource value. This is as utilities develop sources of natural gas. For Kokopelli, DXI Energy retains a 25 percent Working Interest (WI) in 2,200 acres (550 net, 2 leases). 

In addition, DXI has its Roan Creek project (West Piceance Hi-Pressure Mancos/Niobrara Gas). This project is 1,960 net acres, 100 percent WI. There is potential development of 8-10 high pressure Mancos/Niobrara 8200’ vertical/Hz wells.

The Woodrush Project in northeastern B.C. encompasses 14,444 net acres (20.701 (gross) with 12 wells (3 oil and gas, 9 natural gas). DXI is the operator and it owns 99 percent of the Project. The Company has a multi-phase plan to expand production and landholdings at the Woodrush Project. It has $13mm invested in production facilities and a related network of pipelines at the Woodrush Project.

Recently, DXI Energy announced that it received all B.C. Oil & Gas Commission (BCOGC) permits to begin the drilling of a key Halfway formation exploration well at its Woodrush NE B.C. complex. Contracts for the building of road access and an environmentally modified drill pad meeting specs of all First Nation stakeholders were issued; construction is underway.

Chief Financial Officer, Mr. David Matheson, said, "With the permit to drill from the BCOGC (inclusive of all other stakeholders), we will now test the voracity of the Paradigm 3D seismic imaging and interpretation software with the drilling and completion of this important Woodrush Halfway pool test prior to winter 2019 break up."

DXI Energy, Inc. (DXIEF), closed Wednesday's trading session at $0.0116, up 43.2806%, on 5,878 volume with 8 trades. The average volume for the last 3 months is 45,353 and the stock's 52-week low/high is $0.0023/$0.071999996.

chart

AXIM Biotechnologies, Inc. (AXIM)

TopPennyStockMovers, BioSpace, CFN Media Group, Simply Wall St, Promotion Stock Secrets, Insider Financial, Market Screener, Daily Marijuana Observer, Wallet Investor, and SmallCapVoice reported earlier on AXIM Biotechnologies, Inc. (AXIM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter. 

AXIM Biotechnologies, Inc. is a biotechnology company listed on the OTC Markets Group’s OTCQB. It focuses on the research, development, and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products. AXIM discovers and brings to market unique solutions through research and development (R&D), strategic partnerships, and acquisitions through setting the green standard in the industrial hemp industry. Medical Marijuana, Inc. (MJNA) is a major investor in AXIM.  AXIM Biotechnologies has its corporate headquarters in New York, New York.

AXIM’s emphasis is on inventive, proprietary delivery mechanisms for the introduction of cannabinoids and finding solutions for conditions for which there is currently no effective treatment. The Company is advancing its patented controlled-release cannabinoid gum in studies encompassing several indications.

At present, AXIM’s Intellectual Property (IP) portfolio includes two fully issued patents – one patent permitting the use of CBD (cannabidiol) in controlled-release, functional chewing gum, and another patent for chewing gum containing natural and synthetic cannabinoids for the treatment of pain,  and 15 patent applications in different stages of approval.

The Company’s flagship CanChew Plus® contains 10mg of cannabidiol (CBD) obtained from industrial hemp plants. AXIM also has its CanChew+ 50®. This product contains 50 mg of CBD. CanChew+ 50®is undergoing clinical trials in patients with IBS (Irritable Bowel Syndrome).

Furthermore, the Company’s pipeline of IP protected cannabinoid-based products includes MedChew Rx™. This THC/CBD cannabinoid controlled-release chewing gum is to address pain and muscle spasticity in multiple sclerosis (MS) patients. It is the world’s first patented cannabinoid controlled-release chewing gum.

Recently, AXIM Biotechnologies announced that the United States Patent and Trademark Office (USPTO) issued a patent (US 10,172,786) on oral care compositions consisting of cannabinoids, including cannabidiol (CBD) and/or cannabigerol (CBG). The USPTO granted this patent from AXIM Biotechnologies’ patent application filed on December 15, 2015.

Products that the Company could produce under the patent will be made using cannabinoids. The patented formula maximizes the presence of CBD in the oral cavity during brushing. Also, all formulations via this patent will include CBD. AXIM hopes to use this patent in the development of products for the treatment of oral infectious disease. This includes peri implantitis, periodontitis, oral mucositis, and dental pain.

AXIM Biotechnologies, Inc. (AXIM), closed Wednesday's trading session at $0.7195, up 204.4858%, on 10,177,145 volume with 4,973 trades. The average volume for the last 3 months is 470,341 and the stock's 52-week low/high is $0.100000001/$0.925000011.

chart

Sports Field Holdings, Inc. (SFHI)

RedChip, Real Investment Advice, Investors Hub, Marketwired, Simply Wall St, The Street, Zacks, Market Screener, Stockhouse, Stockopedia, Barchart, Wallet Investor, Innovative Marketing, MarketWatch, and Marketbeat reported earlier on Sports Field Holdings, Inc. (SFHI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Sports Field Holdings, Inc. engages in the design, engineering, and construction of eco-safe athletic facilities. The Company, by way of its wholly-owned subsidiary, FIRSTFORM, Inc., is a product development, engineering and design-build construction business. Sports Field considers itself a leader in innovative playing surfaces that focus on player safety and high performance athletic fields. OTCQB-listed, Sports Field Holdings has its head office in St. Charles, Illinois.

Sports Field engages in the design, engineering, construction, and construction management of athletic fields and sports complexes. In addition, the Company supplies its proprietary, technologically advanced, synthetic turf products and systems to the industry. Its two principal lines of business are construction management of sports facilities and synthetic turf sales. Sports Field says that these two lines of business can be categorized as design, development, and manufacturing of sports surfacing products and associated pre-engineered construction systems.

The Company’s FIRSTFORM® subsidiary supplies its proprietary patent-pending products, athletic field systems, and knowledge-based services to the athletic construction industry. For customers, a FIRSTFORM® Architect will customize their design plan. Additionally, a FIRSTFORM® Design Engineer will create their drainage plan. A FIRSTFORM® Project Manager will also manage the entire construction process.

Sports Field Holdings has its "PrimePlay" crumb rubber-free line of synthetic turf products. The Company’s flagship PrimePlay™ products are available and undergoing installation in athletic facilities across the U.S. Sports Field’s PrimePlay® Replicated Grass is crafted to closely mirror natural grass. It has a blade density almost three times greater than conventional artificial turf.

Sports Field also has its Primetrack Accel™ product line. This product features polyurethane derived from premium raw materials and secure traction and optimal slip protection. Primetrack Accel™ also features optimal force absorption, spike resistance, and is available in full range of color options. Primetrack Accel™ also features a uniform, consistent surface with durable performance.

Sports Field Holdings, Inc. (SFHI), closed Wednesday's trading session at $0.0739, up 138.3871%, on 1,000 volume with 1 trade. The average volume for the last 3 months is 5,555 and the stock's 52-week low/high is $0.010999999/$0.302799999.

chart

GT Biopharma, Inc. (GTBP)

NetworkNewsWire, Stockhouse, Infront Analytics, MarketWatch, The Street, Stockopedia, PR Newswire, GuruFocus, InvestorsHub, Insider Financial, Market Screener, OTC Markets, Morningstar, YCharts, Street Insider, and Simply Wall St reported previously on GT Biopharma, Inc. (GTBP), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

GT Biopharma, Inc. focuses on unique drugs for the treatment of cancer and CNS diseases (Neurology and Pain), along with other unmet medical needs. The Company’s lead oncology drug candidate is OXS-1550 (DT2219ARL). It owns the worldwide rights to commercialize OXS-1550. GT Biopharma is based in Tampa, Florida and the Company lists on the OTC Markets’ OTCQB.

GT Biopharma concentrates on innovative treatments based on its proprietary NK-engager and Bispecific Antibody Drug Conjugate platforms. The Company is targeting multiple myeloma, triple-negative breast cancer, non-Hodgkin’s lymphoma, and more. It is doing so with highly potent biopharmaceutical drugs designed for targeted therapy. Its current CNS pipeline products include treatment for neuropathic pain, the symptoms of myasthenia gravis, and motion sickness.

GT Biopharma’s CNS platform focuses on acquiring or discovering and patenting late-stage, de-risked, and close-to-market improved treatments for CNS diseases. Furthermore, the CNS platform focuses on guiding the products through the Food and Drug Administration (FDA) approval process to the NDA.

OXS-1550 is an ADC (Antibody Drug Conjugate) drug. What makes OXS-1550 (DT2219ARL) different from other treatments, such as chemotherapy, is that the design of it is to specifically target and kill cancer cells while reducing damage to normal tissues. OXS-1550 has demonstrated success in early human clinical trials in patients with relapsed/refractory B-cell lymphoma or leukemia. When OXS-1550 binds to cancer cells, the cancer cells internalize the drug and are killed due to the action of cytotoxic payload. 

Researchers at the University of Minnesota Masonic Cancer Center developed the OXS-3550 TriKE technology. This targeted immunotherapy directs immune cells to kill cancer cells while decreasing drug-related toxicity.

Recently, GT Biopharma announced that it presented data demonstrating the effectiveness of its Tri-specific Killer Engagers (TriKEs) for the treatment of acute myeloid leukemia (AML) presented at the American Society of Hematology (ASH) Annual Meeting.

Raymond Urbanski, M.D., Ph.D., Chief Executive Officer of GT Biopharma, said, “We continue to be encouraged by the data from our Trike program being conducted by leading NK cell experts at the University of Minnesota. These findings have supported us with the confidence to proceed with our first-in-class TriKE, Phase 1 study.”

GT Biopharma, Inc. (GTBP), closed Wednesday's trading session at $0.21, up 51.4605%, on 1,005,629 volume with 185 trades. The average volume for the last 3 months is 111,614 and the stock's 52-week low/high is $0.064999997/$0.268999993.

chart

Capstone Companies, Inc. (CAPC)

OTC Markets, InvestorsHub, Investing.com, Stockhouse, and Stockwatch reported on Capstone Companies, Inc. (CAPC), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Capstone Companies, Inc. is a designer of innovative LED lighting solutions including power failure lighting. These are for consumers and institutions. Capstone sells its products under the Capstone Lighting and Hoover® HOME LED brands. Capstone Companies is headquartered in Deerfield Beach, Florida. The Company lists on the OTCQB.

Capstone Companies executed a strategy in 2012 to further nourish its product development efforts. The Company made an investment in AC Kinetics, Inc., to confidentially explore and develop certain unique concepts Capstone conceived. Capstone plans to maximize its proprietary technologies through select licensing arrangements.

Capstone Companies’ business strategy is to use its low-cost manufacturing base to provide high-quality consumer products to its customers at a reasonable price, using primarily direct import distribution. Capstone Companies secured the N.A. trademark license for the Hoover® brand for LED lighting products in 2015.

Capstone is a top designer, manufacturer, and marketer of specialty LED lighting solutions. It is also an innovator of other specialty consumer products distributed in numerous countries. These include Australia, Iceland, Japan, Korea, Mexico, North America, South America, Spain, Taiwan and the United Kingdom (UK).

The Company has a selection of product solutions that address consumers’ power failure requirements with a strong, identifiable brand presence. In 2008, Capstone developed and launched its first power failure product, the 6 LED Eco-i-lite Multi-Function LED light. The Company has expanded its product portfolio addressing the necessity for improved safety and security product applications for consumers’ daily life.

Capstone develops, manufactures, and sells a broad variety of stylish, innovative, and user-friendly LED lighting products. These include bath vanity lights, multi-task lights, patented power failure light bulbs, portable accent lighting, and power failure multi-function handheld lights. Products also include power failure plug-in decorative lighting, multi-function nightlights, outdoor LED fixtures, under cabinet lighting, and wireless motion sensor lights.

Recently, Capstone Companies reported its financial results for Q4 and Full Year 2017. Regarding Full Year 2017 highlights, Total Revenue rose 20 percent to $36.8 million from $30.6 million in 2016.

Gross Profit increased 20 percent to $8.8 million from $7.4 million in 2016. Its Operating Income remained consistent at $3.2 million. Provision for Income Tax rose to $1.03 million from $0.3 million in 2016.

Capstone’s Net Income was $2.08 million from $2.82 million in 2016, because of the tax provision increase. The Company’s Year-end Cash balance increased $2.0 million.

Capstone Companies, Inc. (CAPC), closed Wednesday's trading session at $0.11, up 47.651%, on 67,148 volume with 6 trades. The average volume for the last 3 months is 20,355 and the stock's 52-week low/high is $0.059999998/$0.185000002.

chart

Tiger Reef, Inc. (TGRR)

Investors Hub and MarketWatch reported on Tiger Reef, Inc. (TGRR), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Tiger Reef, Inc. is a diversified producer of ultra premium rums under the Tiger Reef® brand. Also, the Company is a developer of casual dining restaurant properties in the Caribbean under the Mermaid Reef Ocean Grill & Lounge™ brand. The Company formerly went by the name Blue Water Bar & Grill, Inc. It changed its corporate name to Tiger Reef, Inc. in October 2016. 

The Company is a subsidiary of BWG Investments & Development, Ltd. Tiger Reef’s shares trade on the OTC Markets’ OTCQB. Tiger Reef is based in Cole Bay, the Netherlands Antilles.

Tiger Reef has established a new wholly-owned operating subsidiary in St. Maarten, Dutch West Indies under the name Mermaid Reef, B.V.  Mermaid Reef will own and operate the initial Mermaid Reef Ocean Grill & Lounge™ in St. Maarten. 

In May 2017, Tiger Reef announced that its wholly-owned subsidiary, Tiger Reef Spirits, Ltd., entered into a Letter of Intent  (LOI)  with International Spirits & Beverage Group, Inc. (ISBG). ISBG is a Nevada based alcoholic beverage company. It specializes in the development, marketing,  and global sales of innovative wine and spirits brands.

ISBG will assist Tiger Reef with obtaining U.S. regulatory approval for the complete line of Tiger Reef® ultra premium rums. In addition, ISBG will become the U.S. importer of record for Tiger Reef’s complete line of rums.

The Mermaid Reef Ocean Grill & Lounge™ was being developed at Simpson Bay Resort & Marina on the island of St. Maarten, Dutch West Indies. Key elements of the Restaurant floor plan included the restaurant encompassing 2,466 sq. ft. of indoor and outdoor waterfront space.

In October of 2017, Tiger Reef issued its first statement and shareholder update since the Company’s St. Maarten headquarters experienced a direct hit from Hurricane Irma during the early morning hours on September 6, 2017. Tiger Reef’s office headquarters suffered catastrophic damage during the Hurricane Irma storm.

All of the Company’s office equipment, computers, paper files, and more were damaged beyond repair during the storm. However, electronic files were backed up offsite and were recovered. Tiger Reef was renovating a leased waterfront restaurant space in the Simpson Bay Resort & Marina in preparation of opening the first Mermaid Reef Ocean Grill & Lounge™ in time for the 2017 tourist season. In addition, Simpson Bay Resort & Marina and the Company’s restaurant location suffered massive damage and flooding.

Tiger Reef and Simpson Bay Resorts & Marina Management had numerous discussions since the storm concerning the future of the resort and restaurant. Based on the fact that the resort would be closed for a minimum of six months, but probably longer, and other uncertainties, Tiger Reef and Simpson Bay Resorts & Marina mutually agreed to terminate the lease agreement for the restaurant space. Tiger Reef will make a one-time write-off or its lost investment in this restaurant property.

Tiger Reef temporarily suspended all efforts related to the Mermaid Reef Ocean Grill & Lounge™ brand. The Company said this past October that it would re-evaluate its options for the brand in the coming months after it recovers from the losses incurred due to Hurricane Irma.

Tiger Reef, Inc. (TGRR), closed Wednesday's trading session at $0.0002, up 100.00%, on 33,214,119 volume with 24 trades. The average volume for the last 3 months is 36,220,221 and the stock's 52-week low/high is $0.000099999/$0.0024.

chart

The QualityStocks Company Corner

Vivos Therapeutics Inc.

The QualityStocks Daily Newsletter would like to spotlight Vivos Therapeutics Inc..

The global sleep apnea market is expanding rapidly, being expected to reach $13.24 billion by 2027, from $7.81 billion in 2019, exhibiting a CAGR of 6.8 percent. In a report titled “Sleep Apnea Devices Market Size . . .”, Fortune Business Insights notes that the rising cases of cardiovascular disorders and diabetes among the geriatric population are some of the primary causes of the surge in sleep apnea (http://ibn.fm/wlVz2). 

Headquartered in Denver, Colorado, Vivos Therapeutics Inc. is an emerging global leader in the treatment of obstructive sleep apnea (OSA), a debilitating condition affecting nearly 1 billion people worldwide. The company utilizes proprietary, ground-breaking technology, a proven go-to-market strategy, and a powerful executive team dedicated to changing the face of health care by helping people of all ages properly breathe and sleep.

At the core of Vivos’ mission to eradicate OSA is the Vivos System®, a revolutionary clinical breakthrough in the treatment of sleep apnea caused by craniofacial anatomy development. The Vivos System® multidisciplinary treatment protocol involves collaboration between physicians, specially-trained dentists who have completed advanced training in craniofacial sleep medicine, and other ancillary health care providers.

In support of its growth strategy, Vivos has established FDA-approved and registered manufacturing facilities in the U.S., Canada and Asia.

Market & Technology Overview

Craniofacial developmental deficiencies, such as underdeveloped upper and lower jaws, are the leading cause of OSA. According to a 2019 analysis from researchers at the University of California, San Diego, an estimated 81 million adults in North and South America suffer from moderate to severe OSA. The United States has the highest amount of these patients, with approximately 54 million adults affected, according to the report.

Registered with the FDA as a Specification Developer, Vivos develops and markets a number of oral appliances. Its technology represents the first non-surgical, non-invasive and cost-effective solution for the estimated hundreds of millions of people globally who suffer from OSA.

Vivos integrates its specially designed, customized appliances into a patient-specific, multi-disciplinary clinical protocol, giving trained dental and medical providers the tools and roadmap needed to address certain craniofacial conditions that have proven to be associated with sleep-disordered breathing—including OSA.

The system’s treatment protocol involves collaboration between physicians, specially trained dentists who have received advanced training in craniofacial sleep medicine, and additional health care providers. Vivos-trained clinicians can be found in almost every major city in the U.S. and in many countries throughout the world. The company’s oral appliances have shown to be effective in over 15,000 patients successfully treated worldwide by approximately 1,350 trained dentists.

A New Paradigm in Sleep Medicine

Vivos’ proprietary system poses the potential to be the biggest breakthrough in OSA treatment since CPAP.

Designed to promote correct growth and development of the hard and soft tissues surrounding and compromising the oral cavity, nasal cavity, upper and lower jaws, and other tissues which comprise and shape the human airway. The system uses Pneumopedics®, the natural process induced by Vivos biomimetic technology to widen and expand the patient’s airway, allowing for proper breathing through the nose, effectively addressing the root cause of OSA.

This patented technology offers benefits over CPAP and other oral appliances in its ability to achieve results relatively quickly—in about 18 to 24 months or less—at a lower cost, and without the need for lifetime intervention in most patients. It is believed to be the first effective, non-surgical, non-invasive and potentially long-lasting solution to eradicating OSA.


Biomimetic Oral Appliance

A treatment protocol that targets the underlying cause of sleep apnea.

The Vivos System® works to treat the root cause of OSA by non-surgically remodeling and repositioning the hard and soft tissues that compromise the human airway.

The Vivos System® treatment is typically less than $10,000 and is covered by most major health plans.

A potentially serious medical problem with a solution in the dental office.

Hard and soft tissues of the craniofacial complex can be non-surgically remodeled and enhanced using the proprietary Vivos® System devices and clinical protocols.


Strategic Partnership

A cooperative agreement with Benco Dental, the largest family-owned dental distributor in the United States, broadens the reach of the Vivo System. This partnership ensures that all dentists in the United States have access to Vivo’s patented system, on par with Vivo’s vision to provide clinicians with the tools to provide the best alternative solution to treat OSA and well-aligned with Benco’s commitment to evolve the dentistry industry by empowering clinicians with innovative treatment options.

Leadership

R. Kirk Huntsman – CEO, Director
With experience in strategic development, technology acquisition and product planning, key talent recruitment, and target market prioritization, Huntsman brings a broad vision paired with leadership and strategic planning skills. He has significant start-up experience in a diverse range of market sectors, including medical devices, dental management, dental practice valuations and transitions, multi-location retail, financial and capital formation, consulting, outsourced services, imports and exports (China), medical services, and software and technology.

Dr. Dave Singh – Founder, Director
A doctor three times over in dental medicine, craniofacial development, and orthodontics, Dr. Singh was educated primarily in England and has lectured in North America, Europe, Asia, and Africa. The Global Summits Institute recently named Dr. Singh as one of the Top 100 Doctors in Dentistry.


Recent News

chart

Deltec Bank & Trust Ltd.

The QualityStocks Daily Newsletter would like to spotlight Deltec Bank & Trust Ltd..

Deltec Bank & Trust, a leading financial hub for global investors, financiers and entrepreneurs, offers its clients a unique suite of bespoke financial solutions, institutional expertise and highly attentive service geared toward creating a network of opportunities to enhance client wealth. A recent article discussing the company reads, “Founded in 1959, Deltec draws upon the collective experience of more than 150 professionals. These specialists come from a wide array of backgrounds, including private bankers and investment advisors, trust officers, lawyers and certified public accountants, many of whom have previously worked at some of the world’s largest and most prestigious financial institutions.” To view the full article, visit http://ibn.fm/htExy

Deltec Bank & Trust Ltd. is a leading financial hub for global investors, financiers and entrepreneurs. The private and corporate bank offers its clients a unique suite of bespoke financial solutions, institutional expertise and highly attentive service with an aim toward creating a network of opportunities to enhance client wealth. Deltec Bank & Trust Ltd. is the flagship company of the Deltec International Group, a diversified independent financial services group providing a range of financial services including fund administration, corporate advisory, merchant banking, global insurance and digital asset solutions.

Founded in 1959, Deltec draws upon the collective experience of more than 150 professionals. These specialists come from a wide array of backgrounds, including private bankers and investment advisors, trust officers, lawyers and certified public accountants, many of whom have previously worked at some of the world’s largest and most prestigious financial institutions. Deltec specializes in providing its clients with private banking and fiduciary expertise, fund administration, investment management solutions, digital asset financial services, insurance, and corporate and merchant banking capabilities.

Following the purchase of Société Generale’s private banking business in The Bahamas in 2016, Deltec has seen its group-wide assets under management, administration and custody rise to over $12 billion, as of late 2019 (http://nnw.fm/n0YQx).

Deltec Bank has received a number of accolades throughout its lengthy history, most recently being named the ‘Best Private Bank in the Caribbean 2020’ by Global Banking and Finance Review (http://nnw.fm/jx4rS), an award which it also won in 2015. The company was recognized for its outstanding performance and achievements, scoring particularly highly in the following categories:

  • Strong client relations with personal and client-focused services;
  • Highly personalized and innovative products and services; and
  • Continued commitment to providing clients with the best possible financial solutions.

Opportunity within Fintech

Remarkably for a private bank, Deltec Bank & Trust has historically been at the forefront of the digital banking and fintech revolution within the financial services industry. Deltec has also gained renown for its annual conference, with the latest iteration focusing on disruption with financial services (http://nnw.fm/3m0kX). Hosting over 300 delegates, including the Deputy Prime Minister & Minister of Finance of The Bahamas, the conference featured ‘The Innovator’s Marketplace’, a forum providing an opportunity for emerging companies in biotech/life sciences, virtual reality, blockchain, fintech, quantum computing and other cutting-edge industries to pitch their ideas to investors and attendees in 45-minute presentations.

Engagement with the Community

Deltec Bank has long held strong ties within the local community in The Bahamas through its Deltec Initiatives Foundation, which was designed to foster an environment that empowers young Bahamians to drive positive social impact through the power of arts, entrepreneurship and education.

Since 2013, the foundation has discovered, launched and mentored many talented, motivated and driven Bahamian artists, artisans and entrepreneurs. The Deltec Initiatives Foundation comprises three pillars: The Initiative for the Arts, The Initiative for Young Entrepreneurs and The Initiative for Scholarship & Education.

Expert Team of Professionals

Jean Chalopin, chairman of Deltec International Group, is a global business leader with a remarkably diverse background encompassing several industries, including banking, wealth management, biotechnologies and entertainment.

Odetta Morton, CEO of Deltec Bank & Trust, is a seasoned banker and CPA with over 20 years of experience in the financial services sector, including financial management, shareholder relations, business leadership and corporate strategy.

Gregory Pepin, Deputy CEO of Deltec Bank & Trust, is an expert financial strategist with vast experience in blockchain technology, investments, wealth management and insurance.

Fabio Gama, Chief Operating Office of Deltec Bank & Trust, has 15 years’ experience in the financial services industry, Fabio has been directly responsible for operations, IT, facilities and procurement. He is an expert in developing teams and has a proven track record for supporting business needs.

Tanya Carey, Chief Financial Officer of Deltec Bank & Trust, is a resourceful finance professional and licensed CPA with over 20 years of experience in financial services and solid industry and regulatory knowledge.

Terry Girling, Chief Administrative Officer of Deltec Bank & Trust, is a senior executive, chartered accountant and banking professional with over 40 years of experience in the finance and banking sectors. Girling is experienced in all facets of banking, including accounting, compliance, operations, technology, fund administration, trust administration and human resources.

Hugo Rogers, Chief Investment Officer of Deltec Bank & Trust, is a multi-asset investment and award-winning global equity and hedge fund manager. He has actively managed investments for over 15 years. He is also a CFA Charterholder with a master’s degree from Oxford University.


Recent News

chart

DarioHealth Corp. (NASDAQ: DRIO)

The QualityStocks Daily Newsletter would like to spotlight DarioHealth Corp. (DRIO).

DarioHealth Corp. (NASDAQ: DRIO)was featured today in a publication from BioMedWire, examining how a well-trained staff is key to the integrity and success of one’s clinical trial. During busy times, budgets are usually tight. As a result, training in clinical research fails to get the attention it needs. However, training in remote clinical research is affordable. It is an effective alternative to conducting research in different geographical areas during times when movements are limited. There is therefore no time which is better in investing in remote clinical research training than right now.

New York and Israel-based DarioHealth Corp. (NASDAQ: DRIO) leads global digital therapeutics (DTx) with its popular, smartphone-centered personalized chronic illness management software-as-a-service (SaaS). The company’s strategic advantages include:

  • AI-powered digital solutions that drive durable behavior change in chronic disease patients, and
  • Personalized user experience at scale to make behavior change the path of least resistance.

Approximately $3 trillion in annual U.S. costs associated with chronic illnesses like diabetes, hypertension and obesity are largely preventable with behavioral therapies. Formerly limited to periodic office visits, these therapies can now scale to millions with tech-enabled, continual and remote health monitoring, as well as AI-driven digital and live coaching. This is all possible while still maintaining the personalization required for success in reducing illness and its related effects and costs.

Roughly 51,000 active, paying users manage their health with Dario’s platform that combines smartphone-connected vitals measurement, remote patient monitoring (RPM), lifestyle management tools, and AI-driven and human coaching to deliver improved clinical outcomes.

Among the most downloaded medical apps, the Dario platform is rated at 4.9 stars on the Apple App Store and features 11,000 reviews, along with a Net Promoter Score (a measurement of consumers’ willingness to recommend the product to others) that’s the highest in its field.

Company Strategy

Clinical studies demonstrate Dario’s direct improvement on users’ health measures like H1AC scores (diabetes) and blood pressure (hypertension).

Patient engagement in therapies leads to health success. Dario’s platform centers on continual maximization of patient engagement through personalization, including ‘nudges’ and live, AI-generated responses to health measures provided by Dario’s smartphone-connected medical devices.

Proprietary data analysis provides valuable insights that not only improve health care providers’ medical capabilities but, through artificial intelligence, encourage patients to take evidence-based and highly personalized preventative measures that reduce risk, emergency room visits and preventable hospitalization.

Dario is now deploying its successful B2C platform in B2B2C, targeting employers and health plans with competitive advantages in cost, software and hardware.

The company estimates an annual addressable U.S. market of $72 billion, only 1% of which has been penetrated with digital therapeutics.

The strategic transition to B2B2C (from exclusively B2B) is intended to accelerate revenue growth by reducing Dario’s cost per acquisition per user and expanding margins.

Dario’s commitment to aggressive growth is also shown by its appointment of a new president, chief medical officer and head of sales for North America, all from a highflyer behavioral health company.

Key growth drivers planned include expansion of the company’s paying B2C subscriber base; lateral expansion into other chronic conditions that overlap with its core diabetes populations, such as hypertension, obesity and depression; and increased B2B2C penetration.

Financial Highlights

The company plans to leverage a massive opportunity for growth, with a global addressable market for digital therapeutics of roughly $108 billion. In the U.S. alone, that number is estimated at $72 billion, and only about 1% of that market has been penetrated.

Dario’s strategic transition to an SaaS membership business model increased gross profit by 87% in Q1 2020, as compared to the prior year. Membership revenue increased from 27.1% to 46.7% in the same period. The company is seeing improved operating efficiencies as it shifts focus to the B2B2C business model, and it expects average revenue per user per month (ARPU), which was $6 and $25 in 2019 and 2020, respectively, to reach $70.

Value to Consumers and Businesses

Dario continually evaluates and optimizes the value and return its platform delivers to consumers and businesses.

Consumers seeking to understand how their everyday behavior impacts their personal health and chronic conditions benefit from actionable feedback on how to improve health and better collaborate with health care providers.

Businesses looking to increase employee satisfaction, loyalty and productivity with fewer health-related absences take advantage of Dario’s services for employers.

Health care providers improve patient compliance using the platform’s interactive services that allow for greater monitoring, which improve engagement with patients at the right times and with the right treatments.

Health plans can leverage DarioHealth’s solutions to improve patient outcomes and lower costs.

Recent Studies

The company recently presented the results of two new studies at the American Diabetes Association’s 80th Scientific Sessions, which showed sustained improvements in blood glucose levels and blood pressure among users of its digital therapeutic platform for chronic diseases. The results of these two studies demonstrate that the use of Dario’s therapeutic platform promotes behavioral modification, enhanced individual engagement and improved clinical outcomes.

Remote Patient Monitoring (RPM) Agreements

The Centers for Medicare & Medicaid Services recently approved RPM codes for Medicare patients, which enables physicians to bill for between-visit patient care.

This simplifies implementation of the company’s open and scalable AI-driven platform and further supports transition to the company’s high-margin, recurring SaaS model targeting B2B2C revenue channels.

Emergency COVID-19 FDA Guidelines Allow Self-Test Blood Glucose Meters

In an effort to preserve personal protective equipment (PPE) and reduce contact between health care providers and patients in hospital settings due to COVID-19, the U.S. Food and Drug Administration (FDA) has recognized that home-use blood glucose meters, including Dario’s smartphone-connected metering device, may be used by patients with diabetes who are hospitalized due to COVID-19 to check their own blood glucose levels and provide the readings to the health care personnel caring for them.

As a result, hospitals can now allow patients to self-test using their Dario blood glucose testing strips and smartphone-connected devices, or hospitals can issue patients Dario devices upon admission for COVID-19-related conditions.

Irregularities in blood glucose levels are suspected as a factor in the increased severity of potentially deadly COVID-19 complications. As such, a high priority is being placed on stabilization of patients’ blood glucose levels.

Awards and Recognition

DarioHealth’s Blood Glucose Monitoring System was voted as the ‘Best Glucometer for Data Management’ by Top Ten Reviews. Jeph Preece, senior editor at Top Ten Reviews, said, “The Dario app is the best data management system that I’ve seen. Compared to apps by popular brands, Dario’s system looks and feels like it’s years ahead of the curve.”

‘The Global Digital Health 100’, an annual award sponsored by the reputable Journal of Health, recognized DarioHealth as a leader among health technology companies demonstrating the greatest potential to change the way that health care is delivered.

DarioHealth Corp. (DRIO), closed Wednesday's trading session at $6.30, off by 1.5625%, on 16,922 volume with 129 trades. The average volume for the last 3 months is 73,025 and the stock's 52-week low/high is $3.01999998/$13.1260004.

Recent News

chart

Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B)

The QualityStocks Daily Newsletter would like to spotlight Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B).

Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B), on Tuesday announced assay results from the six remaining holes of the 25 recently drilled at its Bullfrog Project (“Project”). The Project comprises 2,125 hectares (5,250 acres) of strategic lands, established resources, and prospective exploration potential in the Bullfrog Mining District, which is located 200 km northwest of Las Vegas, Nevada. To view the full press release, visit http://nnw.fm/8XhL8

Bullfrog Gold Corp. (the “Company”) (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) is a Delaware corporation engaged in the acquisition, exploration and development of gold and silver properties in the United States. The Company controls strategic lands with established 43-101 compliant resources in one of the most exciting gold exploration areas in the United States. The Bullfrog Gold Project (“Project”) includes a lease/option on much of the lands where Barrick Bullfrog Inc., a subsidiary of Barrick Gold Corp., produced more than 2.3 million ounces of gold and 2.49 million ounces of silver from 1989 to 1999. The Project is located within the prolific Walker Trend about 125 miles northwest of Las Vegas, Nevada.

Project Highlights

  • The Company initially acquired 79 unpatented claims and two patents in mid-2011 and has since staked, leased, optioned, or purchased lands that now total 5,250 acres. Via a 2015 lease/option with Barrick, the Project includes the northern one-third of the Bullfrog deposit where most of the current resources in the Bullfrog mine area occur, along with their interest in the Montgomery-Shoshone deposit which gave the Company 100% control.
  • In mid-2017, a NI 43-101-compliant report by independent mining consultancy Tetra Tech Inc. estimated measured and indicated (“M&I”) resources of 624,000 ounces of gold and 1.73 million ounces of silver at average grades of 0.70 g/t and 1.93 g/t, respectively. The expansion plans of these two pits were based on a $1200 gold price, use of heap leach processing, and also included 110,000 ounces of inferred gold resources averaging 1.20 g/t. Barrick used conventional milling to process an average gold grade of 3 g/t.
  • The established resources and exploration potential of the Project are strongly supported by a large data base obtained from Barrick, including detailed information on 155 miles of drilling in 1,262 holes in the Bullfrog mine area.

Gold Rush in the Bullfrog Territory

The area around Beatty, Nevada has now attracted AngloGold Ashanti, Kinross Gold, Corvus Gold, Coeur Mining as well as the Company and Waterton. In this regard, Northern Empire Resources Corp’s property located a few miles east of the Project was acquired by Coeur Mining in October 2018 for C$117 million, implying a valuation of C$134/oz of inferred resources. As of today, the Company is trading at a significant discount to the valuation at which Northern Empire was purchased (http://nnw.fm/9NaaN), thereby highlighting the Company’s value proposition for investors.

Bullfrog Gold Corp. is focused on enhancing shareholder returns by concurrently advancing Project development and performing exploration drilling programs on several targets identified by the Company.

Secured Financing for 2020 Operations

Bullfrog Gold Corp. raised C$2 million in January 2020 through a private placement of shares priced at C$0.13/share plus a one-half warrant exercisable within two years at C$0.20 on a full warrant basis. The raise was carried out primarily to fund a drill program that started on May 1 (http://nnw.fm/6nZ0m), and was completed on June 6, 2020. Results from drilling 12,520 feet in 25 holes will be released in the coming weeks. The Company subsequently intends to conduct a preliminary financial analysis and complete further drill programs to advance the Project and add value. The financing was subscribed by several influential shareholders, including a former director of Northern Empire, who handled the sale of the company to Coeur Mining, and Eros Resources, the management of which has been involved with several high-profile mining projects and sales in the past.

Gold Prices estimated to average $1,800/oz in 2021

Gold prices have been on a remarkable run in 2020, rising by $245/oz to $1,760 prior to peaking in early May. Global central banks carried out 144 interest rate cuts thus far in 2020, reducing their rates by a cumulative 5,035 basis points (http://nnw.fm/jzZt0). Meanwhile, the IMF has estimated that global governments have introduced fiscal support measures amounting to over $9 trillion since the start of the COVID-19 pandemic (http://nnw.fm/Or9rI). The resulting weakness in the U.S. dollar and eventual inflationary pressures stemming from these measures prompted Credit Suisse to recently hike their gold price forecasts for the full year to $1,701/oz (from $1,570 previously), while the outlook for 2021 has been raised to $1,800/oz (versus $1,600 previously) (http://nnw.fm/Iqg0X).

Management Team

David Beling, CEO, President and Director
David Beling is a Registered Professional Mining Engineer with 55 years of diverse experience in areas such as engineering, development, permitting, construction, financing and management of mines and plants and the building and growth of several corporations. His initial employment included 14 years with Phelps Dodge, Union Oil, Fluor, United Technologies, and Westinghouse, followed by 41 years of senior management and consulting with 25+ U.S. and Canadian mining companies. In 2006-2007, he spearheaded an IPO, successfully drove equity raises totaling C$112 million and grew that Company’s market capitalization to $460 million. Beling has served on 14 boards since 1981, including three mining companies distinguished by the TSX Venture Exchange as top-10 performers.

Alan Lindsay, Chairman of the Board
Alan Lindsay is an entrepreneur and businessman who has founded seven companies within the mining and pharmaceutical industries, including Anatolia Minerals Development Ltd., Uranium Energy Corp., Oroperu Mineral, Strategic American Oil and AZCO Mining. Lindsay also developed the strategic vision for the 2011 acquisition and placement of the Project from NPX Metals into Bullfrog Gold Corp.

Kjeld Thygesen, Director
Kjeld is a graduate of the University of Natal in South Africa and has 48 years of experience as a resource analyst and fund manager. In 1972, he joined James Capel and Co. in London as part of its highly rated gold and mining research team before subsequently becoming manager of N. M. Rothschild & Sons’ commodities and Natural Resources Department in 1979. In 1987, he became an executive director of N. M. Rothschild International Asset Management Ltd., before co-founding Lion Resource Management Ltd., a specialist investment manager in the mining and natural resources sector, in 1989. Thygesen has been a director of Ivanhoe Mines Ltd. since 2001 and served as investment director for Resources Investment Trust PLC from 2002 to 2006.

Tyler Minnick, CFO and Director of Administration & Finance
A registered member of the Colorado Society of Certified Public Accountants with over 24 years of experience within the fields of accounting, auditing, and administrative services. Minnick has been engaged with the Company since mid-2011 and previously worked in the finance department of MDC Holdings/Richmond American Homes, one of the largest residential construction companies in the United States.

Bullfrog Gold Corp. (OTCQB: BFGC), closed Wednesday's trading session at $0.18, up 5.8824%, on 889,021 volume with 138 trades. The average volume for the last 3 months is 179,185 and the stock's 52-week low/high is $0.047449998/$0.209999993.

Recent News

chart

ISW Holdings (ISWH)

The QualityStocks Daily Newsletter would like to spotlight ISW Holdings (ISWH).

ISW Holdings (OTC: ISWH), a brand-management portfolio company with diverse partnerships, looks to be particularly astute at recognizing growing businesses in multiple sectors. The company has partnerships in crypto mining, renewable energy, wellness and restoration, and the adult-beverage industry, as well as early-stage operations in supply chain and logistics management. Most recently, the company has announced it is launching its proprietary telecare technology service as part of its successful and growing home healthcare business (http://ccw.fm/U7BwO).

ISW Holdings (ISWH) (“ISW Holdings”) is a brand management portfolio company with diverse partnerships that focus on growing businesses in multiple sectors, including crypto mining, renewable energy, home health care for the chronically ill, wellness and restoration, and the adult beverage industry, as well as early-stage operations in supply chain and logistics management. ISW Holdings operates as the nexus between its partnerships and their essential services for end users.

Mission
The company’s core mission is to enhance these sectors by implementing innovative services and products ready to meet the demands of a changing world. To that end, ISW Holdings leverages its strategic expertise, resources, and innovative software to establish market-leading companies and partnerships, which ensure their success in their chosen industries. This enables the company to return maximum shareholder value with its focus always on its partnerships’ various sector volatility.

The Revolution
Positioned to create industry leaders, the company’s process entails strategic development and aggressive early growth of its partner brands to establish them as profitable and viable. ISW Holdings’ method is to nurture emerging partner brands through the essential stages of market development (from conceptualization to distribution) in sectors relevant to today’s marketplace. In addition, the company has a holistic approach to business development, with every strategy being delivered person-to-person from developers to end users.

The Challenge
The company’s goal is to turn its target audience into loyal consumers by ensuring transparency and a clear understanding of its products and services, thus creating visibility, credibility, and trust.

ISW Holdings’ Innovative Approach
ISW Holdings has diversified positions in its partnerships across technology, health care, wellness, renewable energy, and the adult beverage sectors. The company seek to provide industry leading modern solutions to its clients and sound business practices to its partners. This is accomplished through an early growth platform that cultivates its partnerships with the necessary resources and expertise to expand exponentially.

ISW Holdings’ Opportunity
The company’s opportunity is considerable. In the ever-changing high demand global marketplace, the need for timely innovation is critical. ISW Holdings’ portfolio brand management and creative thinking has allowed the company to develop and deploy enterprises that meet the needs of 21st century consumers. Through a fully vetted system of scalability, it is able to meet consumer demands with turn-key solutions.

Portfolio of Partnerships and Businesses
ISW Holdings’ diverse portfolio reflects the growing demand for essential services in a dynamic modern operational landscape. With partnerships that incorporate a depth of experience and industry insight, ISW Holdings has established itself as a portfolio company in technology, home health care, and wellness, with a focus on reshaping industry benchmarks.

Bit5ive

ISW Holdings operates a joint venture with Bit5ive, a global leader in cryptocurrency mining. As an official distribution partner of Bitmain (the industry’s leading fabless manufacturer of computing chips and distributor of Antminers to more than 30 countries in Latin America, Central America, and the Caribbean), Bit5ive is quickly becoming one of the largest U.S.-based companies in the cryptocurrency mining and bitcoin farm sectors of the market.
Valued at $293.66 million in 2019, the bitcoin technology market is expected to reach $477 million by 2025, according to Mordor Intelligence. The joint-venture agreement enables ISW Holdings to collaborate with the experienced team at Bit5ive to innovate the infrastructure needed to run profitable and efficient crypto mining projects.

Proceso, LLC

With a growing awareness of the importance of renewable energy worldwide, ISW Holdings has partnered with Proceso, LLC to create high-density processing and mobile data centers powered by renewable energy. These innovations will allow Proceso to offer lower-cost and diverse services to its clients, including hosting and colocation services to growing sectors such as the gaming industry and cryptocurrency mining – two fields with a typically high energy demand.

Because crypto mining companies mostly operate outside of the United States with higher asset security risks, Proceso will assist these entities in securing their investments by providing a local source of power and infrastructure development. This is aimed at helping to reduce power consumption while creating secure crypto mining data centers in the U.S. For the gaming industry, Proceso is ready to tackle one of its biggest problems, latency, by building next-level infrastructure in key locations.

PHH – Home Health

PHH Paradigm Home Health answers the growing need for homecare services in a world where health care delivery is changing and an increasingly large aging community is looking for efficient and effective ways of accessing health care. PHH aims to be at the forefront of this change by offering quality care services infused with new emerging technologies.

ISW Holdings’ home health division is currently developing a pilot for on-demand health care, which consists of a dedicated, stable platform for different medical services. The platform will offer greater freedom of choice and transparency by allowing users to find outpatient clinics in their vicinities, compare costs, and pick the most suitable choices. PHH is also developing specialized technology and tools to support health care services outside of the bounds of specialized facilities by focusing on homecare facilities. This can not only shift the burden from hospitals and clinics, but also streamline specific parts of the health care process to enhance service and product distribution.

VOLUM

ISW Holdings’ logistics and supply chain management division was designed with the core goal of increasing supply chain efficiency as one of the key aspects of successfully growing any business. The VOLUM project’s focus is on identifying and then implementing advanced supply chain management strategies and methods that will enable ISW Holdings’ partner companies to scale and grow exponentially. To achieve this goal, the company develops and offers reliable systems and solutions that create innovative technologies and unmanned system operations for overall higher cost-effectiveness.

In the wellness sector, ISW Holdings has opted for a two-pronged approach to create effective, technologically advanced products, as well as developing innovative ways to educate customers about these products. To this end, ISW Holdings has partnered with BioPulse to achieve state-of-the-art research and development and production capabilities, as well as a direct route to market. The company plans to design and launch up to five unique brands in the wellness and restoration sector in 2020.

ISW Holdings is committed to developing product and service innovation in the consumer spirits and adult beverage industry, which faces increasingly strict regulations but growing demand. The company has been a key innovator in the industry for 25 years, having grown successful luxury brands such as Besado Tequila and others. By leveraging its expertise, ISW Holdings can help companies in the adult beverage industry increase production, streamline their supply chains, implement better processes, innovate their marketing strategies, expand into new areas, and build sustainable relationships with partners and customers.

Management Team

Terry Williams, Chief Executive Officer and Director
Terry Williams brings to the company more than 30 years of experience in accounting and information systems, logistics, insurance, and transportation. With a Bachelor’s and Master’s degree in accounting and management information systems, Williams amassed considerable corporate experience at United Parcel Service, where he took several logistical roles, including controller, where he managed more than 2,000 employees and a budget of more than $10 billion.

Williams also serves as president of Airwave Transportation and logistics and chief financial officer of AVI Insurance Caribbean, and he has worked in over 37 domestic and international airports. In 2013, he received the National Airport Minority Advisory Council Award for mastering skills in the aviation industry.

Alonzo Pierce, Chairman
Alonzo Pierce is chairman of ISW Holdings and brings a wealth of business development and wealth management experience to the ISW team. He has spent the past 20 years building recognizable brands in multiple industry sectors. He has launched enterprises in life-styled brands which were delivered to high-profile, high-net worth families and individuals. He has worked in the adult beverage industry, establishing a formidable background in marketing and brand creation. Pierce has a B.A. from Baylor University and has received multiple awards in the adult beverage industry, including ‘Outstanding Sales Performance in the Southern Region’ for Sapphire Brands, including selling the world’s only black vodka. He served as regional director for Sapphire Brands, covering the Southwest and Southeast regions. Pierce also served as a national liaison to a Super-Regional Bank’s private wealth division. In addition to his for-profit endeavors, Pierce has served on multiple charitable boards, sourcing funding for JRA, food insecure families and housing insecure families.

Kristina Mahoney-Brown, Secretary, Treasurer, Director
Kristina Mahoney-Brown is secretary and treasurer as well as director of ISW Holdings. With more than 20 years of experience providing tax and financial consulting to real estate companies, as well as investors, developers and construction companies, Mahoney-Brown has gained solid business expertise and market knowledge and prides herself on staying abreast of the latest industry trends. Her professionalism, impeccable work ethic and advanced marketing strategies have earned her the nickname ‘The Tax Diva’. Mahoney-Brown has a Bachelor’s in accounting, a Master’s in taxation and a Master’s in business administration, specializing in personal financial planning.

ISW Holdings (ISWH), closed Wednesday's trading session at $0.19, off by 17.2113%, on 22,605 volume with 23 trades. The average volume for the last 3 months is 20,910 and the stock's 52-week low/high is $0.109999999/$8.00.

Recent News

chart

Champignon Brands Inc. (FWB: 496) (CSE: SHRM) (OTC: SHRMF)

The QualityStocks Daily Newsletter would like to spotlight Champignon Brands Inc. (CSE: SHRM).

Champignon Brands Inc. (FWB: 496) (CSE: SHRM) (OTC: SHRMF) was highlighted in a publication from FinancialNewsMedia.com, examining how, over the last few years, all the talk has been about cannabis, cannabis… cannabis. CBD, CBG, THC and so on… but recent reports see the spotlight moving onto a different new "old" player. Its been said in a recent article that: "The global march toward cannabis legalization has seemingly awoken another long dormant area of scientific interest: psychedelics as medicine. While the idea of using LSD, MDMA, and psilocybin (the main hallucinogenic compound in magic mushrooms) to treat mental health disorders is far from a trail-blazing concept, this whole area of research had been off limits for the better part of the last 50 years. Then, something strange happened… In 2018, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation (BTD) (for) psilocybin therapy for treatment-resistant depression. A few months later, the agency awarded (another) BTD for psilocybin therapy for major depressive disorder. In lockstep with the FDA's more open-minded approach toward psychedelic medicine, Denver, Oakland, and Santa Cruz all decided to decriminalize magic mushrooms. Hundreds of other U.S. cities are reportedly considering similar measures at the moment." 

Champignon Brands Inc. (FWB: 496) (CSE: SHRM) (OTC: SHRMF) is a research-driven company specializing in the formulation and distribution of a suite of artisanal mushroom health supplements. Dedicated to revolutionizing conventional organic teas, coffees and other consumables with the infusion of a proprietary blend of artisanal mushrooms, Champignon’s expanding portfolio is crafted with the health-conscious consumer in mind.

Headquartered in Vancouver, British Columbia, Champignon’s team aims to promote the health and wellness benefits of functional mushrooms, which are used in a wide variety of health care and pharmaceutical products.

Brands

Champignon’s mushroom-derived consumer packaged goods (CPGs) portfolio includes its flagship brand, Vitality Superteas. Each carefully curated Vitality Supertea formulation was developed with the intent of helping individuals enhance and enrich their wellbeing one cup of mushroom-infused tea at a time.

Also in the portfolio are Nourish Force Supertea, a blend of Reishi Ryobus Tea Mix; Mighty Recharge Supertea, created with Lions Mane Tropical Green Ginseng Tea Mix; and Brain Enhance Supertea, a blend of Cordycep Hibiscus and Berries Tea Mix – all of which are formulated with organic ingredients and chosen for their ability to provide unique health and performance benefits.

Champignon’s flagship e-commerce store, VitalitySuperTeas.com, takes advantage of the burgeoning craft mushroom vertical space with a selection of mushroom-infused teas and accessories.

Functional Mushroom Market

Demand for consumer products infused with the nutritional and bioactive benefits of mushrooms is fueling a global market projected to reach $34.3 billion by 2024, growing at a compound annual growth rate of 8.04% from 2019-2024 (ResearchandMarkets), with Europe seen as the fastest growth leader.

According to the market study, in highest demand are products infused with Reishi – a traditional Chinese medicine also known as the “Elixer of Life” and “Mushroom of Immortality – Lions Mane and Cordyceps, followed by other types of medicinal mushrooms.

Advances in Legalization

Legalization of psychedelics for use in medicine is gaining momentum across the United States. Denver, Colorado, and Oakland and Santa Cruz, California, have decriminalized the use of psilocybin, the psychedelic molecule found in various mushrooms, while movements for legalization are gaining ground in Oregon and Iowa, among others. Decriminalize California recently teamed up with the Beckley Foundation to replicate Oakland’s success of decriminalization throughout the state of California.

An increasing number of researchers are turning their attention toward the study of psilocybin as a means to treat otherwise untreatable illnesses. The molecule’s ability to provide landmark treatment options for depression, post-traumatic stress disorder (PTSD), migraines and addiction is gaining widespread acceptance among medical professionals, unicorn investors and accredited institutions.

Potential Applications

Historical data and new scientific studies suggest therapeutic benefits of psychedelics in many areas, including drug addiction, alcoholism, depression, migraines, smoking cessation and post-traumatic stress disorder (PTSD).

The market potential in these areas are significant. To reference just one of the above conditions, the mental health arena has been frequently neglected over the last 30 years, though new research is beginning to further reinforce that psychedelic compounds have the potential to produce more effective treatments than what is currently available.

According to the World Health Organization, 25% of the world’s populous will be afflicted by mental health and/or neurological disorders. Presently, approximately 450 million people currently suffer from such conditions, placing mental disorders among the leading causes of ill-health, productive loss and disability worldwide.

Additionally, PTSD affects approximately 2.2% of the U.S. population; 7.7 million people will have PTSD at some point in their lives. Recent published studies have demonstrated the safety and efficacy of certain psychedelics when administered in a medically supervised and monitored approach.
A renaissance in alternative medicines is emerging, and Champignon has set in motion its strategy to become a key player.

2020 Stealth IP Strategy

Champignon plans to biosynthesize psilocybin within the first three months of conducting laboratory experiments, with the objective of achieving optimized and scaled production of pharmaceutical-grade psilocybin for deployment in clinical settings. This strategy includes:

  • Alternative medicine (psilocybin) IP aggregation
  • Development of cGMP formulations of bioactive compounds extracted from plants and Fungi
  • Drafting of benchmark SOPs (Standard Operating Procedures)
  • Patient aggregation, focusing on veterans

Defining a New Asset Class: Psychedelic-Inspired Medicines

In the third quarter of 2020, Champignon – through clinical trials, a compelling IP portfolio and clinical pipeline and drug development platform – plans to advance its pursuit of treatments underpinned by psychedelic substances. This strategy is broken down into two ties:

  • Non-Hallucinogenic Medicines
    • Microdosing Psilocybin/LSD
    • MDMA, commonly known as ecstasy
  • Hallucinogenic Medicines
    • Psilocybin high dose
    • LSD high dose

Partnerships

Companies worldwide are beginning to incorporate functional mushrooms into their product offerings, taking advantage of growing consumer awareness of known health benefits of the ingredients found in mushrooms.

Champignon in November 2019 entered into a distribution partnership with Eurolife Brands Inc. (CSE: EURO), a leading global markets cannabis brand empowering the medical, recreational and CPG cannabis industry worldwide through a data-driven CBD marketplace supported by exclusive and unbiased physician-backed cannabis education and detailed consumer analytics. Under the agreement, Champignon’s branded products are integrated into Eurolife’s e-commerce platform, along with potential distribution opportunities in select brick-and-mortar retail locations in Europe.

Champignon also has an R&D/production formulation agreement with Drip Coffee Social Ltd., located in Nanaimo, British Columbia, which calls for the infusion of Champignon’s proprietary mushroom extract blend into a suite of cold brew coffee products and signature in-house formulations.

Leadership

Gareth Birdsall, CEO, Corporate Secretary and Director
Gareth Birdsall has more than seven years of experience working in diverse agricultural roles such as the cultivation of various fungi, in particular Cordycepes, Reishi, Lions Mane and Chaga. He is an attendee of the British Columbia Institute of Technology, studying marketing management and finance.

Steven Brohman, CPA, CFO
Steven Brohman has more than 10 years of experience working in a variety of roles with public and private companies. He has had extensive training in the audit of publicly traded companies on the TXS, TSX Venture Exchange and OTC markets, and serves as CFO and director of various public and private companies. Brohman has a bachelor’s degree of business administration and obtained his Chartered Professional Accountant designation.

Jerry Habuda, Director
Jerry Habuda brings to Champignon over 35 years of expertise in law enforcement and specialized units. From 1977 to 2012, he served as a police officer with the Toronto Police Department. During his tenure, he was assigned to the Major Crimes Unit, investigating robberies and home invasions. He was assigned to patrol the Toronto Community Housing projects at Jane/Finch to control drug trafficking and gun violence. Habuda was with the Warrant Unit where he tracked down and arrested wanted criminals. From 1993-1997, he was assigned to the Northwest Drug Squad on undercover and surveillance work, executing narcotic search warrants. Between 2002 and 2004, Habuda headed the Street Violence Task Force, a special unit designed to curb gun and drug violence that was terrorizing the city at the time.

Champignon Brands Inc. (CSE: SHRMF), closed Wednesday's trading session at $0.4699, off by 4.102%, on 467,913 volume with 196 trades. The average volume for the last 3 months is 693,895 and the stock's 52-week low/high is $0.221/$1.74.

Recent News

chart

Trxade Group Inc. (NASDAQ: MEDS)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (NASDAQ: MEDS).

Not in recent memory have medical services and associated support personnel been viewed as more vital to the nation. Just as indispensable, but not as visible, are the supply chain channels through which medical supplies flow, for doctors without medicines may be so handicapped as to be useless. So too would be pharmacies where the bulk of medicines are dispensed. As a result, it is crucial that these supply chain channels operate efficiently. One company has been working specifically toward that end. Trxade Group (NASDAQ: MEDS) has developed an integrated drug procurement and delivery platform that is improving supply chain and market efficiency, speeding up distribution of drugs while also ensuring critical transparency on prices. Also today, NetworkNewsWire released a report on the company detailing today announced plans to release financial results for the second quarter ended June 30, 2020, after market close on Monday, July 27, 2020. According to the update, Trxade Group management will host a conference call at 5:00 p.m. Eastern Time, also on July 27, to discuss the company’s second quarter financial results and conclude with a Q&A from participants. Interested parties may participate by dialing 1-877-425-9470 (U.S.) or 1-201-389-0878 (International) and entering Conference ID: 13707025. To view the full press release, visit http://nnw.fm/m8H6S

Trxade Group Inc. (NASDAQ: MEDS) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade’s overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company’s pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, “E-Bay/Kayak-like” technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the “consumer side” of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called “Delivmeds” (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade’s Managed Services Organization (“TrxadeMSO”) enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient’s information, thereby ensuring appropriate medication coverage based on the patient’s location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade’s fair online market platform targets the nation’s retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE’s programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.  
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks (“PAC”) to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry. 
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE’s advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process. 

Management Team 

Trxade’s management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary
Suren Ajjarapu has served as Trxade’s chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer
Prashant Patel has served as Trxade’s full-time president and COO, and as a director since the company’s acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (MEDS), closed Wednesday's trading session at $6.13, up 12.2711%, on 25,948 volume with 275 trades. The average volume for the last 3 months is 54,115 and the stock's 52-week low/high is $3.23399996/$11.6000003.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade, Inc. (SGMD) was featured today in the 420 with CNW by CannabisNewsWire. Back in December 2018, Congress passed a bill legalizing the cultivation and sale of industrial hemp and its derivatives. CBD or cannabidiol is one of the chemicals produced by the cannabis plant, and research has found it to be effective against a wide range of medical conditions. An industry quickly grew to cater to the rising demand for CBD and by the time tons of companies were marketing and selling CBD products, the industry was still barely regulated.

Sugarmade, Inc. (SGMD) is headquartered in Monrovia, California, where the company recognizes new opportunities in the cannabis delivery space and in the market for supplies to the quick-service restaurant industry – both of which have fast-changing dynamics due to the recent outbreak of coronavirus in the United States.

The Coronavirus Cannabis Boom Market

Retailers across the nation are closing their doors and curtailing operations due to the coronavirus pandemic, inherently pinching sales. In the California cannabis sector, however, business has never been better – especially relative to home delivery.

California’s cannabis industry continues to operate, and media reports reveal booming cannabis sales as the state’s citizens stay home to wait out current events. The Los Angeles Times recently published the headline, “Marijuana Sales on Fire amid Virus Outbreak; New York Post “Cannabis sales hit new highs”; USA Today “American Stock Up on Pot” Fox News “California marijuana sales surge”; and ABC News Cannabis Shops thrive in coronavirus pandemic.

The state of California benefits from the ultra-high taxes paid by the highly regulated cannabis industry, and has thus deemed cannabis companies as “essential” businesses, allowing for full operations to continue. While pot shops are seeing strong foot traffic, the real growth action is in-home delivery as consumers seek to embrace social distancing. Many delivery operators are reporting difficulty in meeting demand with sales growth of up to 10% sequentially each week. It is certainly a boom time for the industry.

Sugarmade Growth Strategy

Recognizing new investment and operational opportunities within California’s cannabis market, Sugarmade is strategizing to take advantage of opportunity specifically in delivery services (non-storefront retailer), manufacturing via co-branding, and selective genetic cultivation. The company is taking a highly selective approach, targeting only the best of these opportunities for company growth.

In line with this strategy is northern California delivery service Budcars, in which Sugarmade owns a 40% interest and an option to gain a controlling interest. Budcars connects consumers with premium products sourced from top-tier farms and extractors, offering a curated menu of fully compliant cannabis products. The company maintains a competitive advantage by sourcing premium cannabis offerings and same-day delivery. In addition to maintaining its own cars, California licenses, and fulfillment center, Budcar orders its premium products in bulk at lower prices, enabling the company to rein in costs and maintain competitive pricing for its customers. Currently serving major communities within the metropolitan area of Sacramento, Budcars plans to continue the expansion of the company’s delivery reach.

Sugarmade plans to continue its expansion into burgeoning new sectors of the cannabis market through the following avenues:

  • Geographic expansion of Budcars delivery scope
  • New delivery geographies
  • Cannabis cultivation as a key component of a hybrid vertical integration strategy
  • Product technology expansion—including products containing exotic and lesser-known cannabinoids

 

Diversified Portfolio

Sugarmade has positive market exposure to cannabis delivery, as well as to the restaurant industry, at a time when these businesses are being force to move toward take-out and delivery models in order to survive.

The company has various business operations in diverse marketplaces, including food, safe packaging and sanitary supplies for various industries, and agricultural supplies. Sugarmade entered the industrial hemp and CBD space by investing in Hempistry, Inc., a privately held Nevada corporation. Hempistry began planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 5,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3% of THC, the psychoactive ingredient found in cannabis.

CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high-quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30%-40% of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Market Opportunity

There is little doubt among industry participants, and recently confirmed by Forbes, that California is the single largest cannabis market in the world. The state is expected to produce more than $3.5 billion in cannabis sales during 2020, with growth topping 23% annually. The global industrial hemp market size was estimated at $4.71 billion in 2019 and is expected to register a revenue-based CAGR of 15.8% over the forecast period of 2016-2027, according to Grandview Research. Market growth drivers include the 2018 Farm Bill and society’s increasing knowledge of the benefits of hemp products.

Overall industry growth is great, but specific vertical sector growth is even better. Cannabis delivery is clearly the fastest growing sector of the marketplace and with coronavirus fears the already robust growth rate has accelerated.

Sugarmade seems to be in the right industry at the right time in history.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick-service restaurant industry, which merged with Sugarmade in 2014.

Dedicated to getting the highest caliber of THC and CBD to its customers’ door, the company’s priority is to ensure that they receive the highest quality cannabis product free from logistical hassles. Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed Wednesday's trading session at $0.0028, off by 6.6667%, on 100,423,405 volume with 480 trades. The average volume for the last 3 months is 59,443,706 and the stock's 52-week low/high is $0.001599999/$0.021999999.

Recent News

chart

National Storm Recovery Inc. (OTC: NSRI)

The QualityStocks Daily Newsletter would like to spotlight National Storm Recovery Inc. (NSRI).

National Storm Recovery (OTC: NSRI) is making a variety of moves to prepare for a potentially rough season of storms and devastation. A recent article discussing this reads, “National Recovery Services recently received final zoning approval for its 100-acre site in Lake County, Florida, which will serve as the company’s flagship tree-debris collection site, as well as a storehouse for NSRI’s mulch manufacturing, soil composting and production bagging. In addition to the zoning approval, the company has signed three substantial agreements for the upcoming storm season, expectations of which range from above average to record breaking regarding its potential devastation (http://nnw.fm/t7wWu).” To view the full article, visit: http://nnw.fm/gmJ7I

National Storm Recovery Inc. (OTC: NSRI), through its subsidiaries, including National Storm Recovery, LLC (DBA Central Florida Arbor Care and Mulch Manufacturing, Inc.), provides tree services, debris hauling, removal and bio-mass recycling, manufacturing, packaging and sales of next-generation mulch products. The company’s primary corporate objective is to provide a solution for the treatment and handling of tree debris that is historically sent to local landfills and disposal sites, creating an environmental burden and pressure on disposal sites around the nation.

Environmentally Friendly

National Storm and the solutions provided by its Sustainable Green Team are founded in sustainability. The company’s vertically integrated operations begin with the collection of tree debris through its tree services division and collection sites. Tree bio-mass is then moved through the processing division for recycling and manufacturing into a variety of organic, attractive, next-generation mulch products to be packaged and sold to retailers, landscapers, installers and garden centers.

The company’s solutions create a synergistic and environmentally beneficial solution to tree and storm waste disposal that historically has created an environmental burden on landfills and disposal sites around the nation.

National Storm’s customers include governmental, residential and commercial customers and now big box retailers. The company is headquartered in Florida.

Strategic Acquisition

National Storm in February 2020 acquired 35-year-old industry leader and innovator Mulch Manufacturing, Inc., an Ohio corporation. Structured as a share exchange, this strategic partnership provides National Storm with a significantly larger footprint in the mulch industry.

The acquisition includes Mulch Manufacturing’s national and international distribution agreements, an increase in production and packaging capacity, and its sales contracts with numerous big box retailers. Mulch Manufacturing includes mulch production, sawmill operation, Natures Reflections colorant manufacturing and equipment manufacturing.

Next-Gen Products

National Storm’s vision and commitment to the environment is paired with Mulch Manufacturing’s revolutionary “next-generation” mulch product, Nature’s Reflection’s Softscape®.

Softscape mulch products, created from natural forest products, are color-enhanced with environmentally safe colorants to provide four-year color retention and are free from contaminants. Safe for people and pets, Softscape allows water and air to penetrate soil and roots, which is vital to plant health and growth.

Expansion Plans

National Storm plans to expand its operations through a combination of organic growth, through its partnership with a nationally recognized waste disposal company, and through strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified.

The company has received final zoning approval for its 100-acre site, located in Lake County, Astatula, Florida, which will serve as the company’s flagship tree debris collection site. The facility will also house the company’s mulch manufacturing, soil composting and production bagging. This prime location includes a 5,000-square-foot building that contains warehouse and office space. The 100-acre property can accommodate millions of cubic yards of organic debris and will allow National Storm’s debris hauling division to realize significant savings on its transportation costs.

National Storm has chosen as its new headquarters the Mulch Manufacturing 100,000-square-foot building in Jacksonville, Florida. The facility comprises centralized operations of Mulch Manufacturing, Inc. and National Storm Recovery, LLC, and has ample room to expand as the needed.

Leadership

National Storm’s Sustainable Green Team boasts more than 40 years of next-level experience with mulch manufacturing, treating and caring for trees. This team is guided by a roster of highly qualified professionals:

  • Tony Raynor, Chief Executive Officer
  • Edward Lee, Chief Operating Officer
  • Ralph Spencer, Director of Business Development, Strategic Acquisitions
  • Steve Ogden, ISA-Certified Arborist
  • Rick Starcher, Master Chemist
  • Peder K. Davisson, Esq., Corporate/Securities Counsel

National Storm Recovery Inc. (OTC: NSRI), closed Wednesday's trading session at $0.9999, off by 0.01%, on 1,480 volume with 5 trades. The average volume for the last 3 months is 1,265 and the stock's 52-week low/high is $0.05/$2.19000005.

Recent News

chart

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF)

The QualityStocks Daily Newsletter would like to spotlight Exro Technologies Inc. (OTCQB: EXROF).

Exro Technologies (CSE: XRO) (OTCQB: EXROF) and Australia's SEA Electric Pty Ltd. ("SEA Electric") are partnering to enhance electric powertrain technology for heavy-duty trucks and delivery vehicles. According to the update, Exro and SEA Electric, recognized as a global leader in the electrification of commercial vehicles, will co-develop and test powertrains based on Exro's Coil Driver and the SEA-Drive technologies. To view the full press release, visit http://nnw.fm/Cp5KW

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), a Canadian technology company, is an innovative pioneer in the energy sector. Exro has developed and commercialized an electric power module (EPM) that integrates into existing motor systems to make them smarter. Exro’s patented technology optimizes existing motor performance by automatically sensing and adapting operating parameters to an optimized state, creating measurable efficiency gains, reduced mechanical components and increased system availability.

Applications

Exro’s technology and efficiency optimization algorithms improve the performance and efficiency of electric motors by manipulating power delivery to individual coils, thereby enabling the ability to expand operating parameters. This novel approach is scalable and can be utilized in most variable torque applications.

The widespread applications of Exro’s technology apply to optimizing the performance of electric vehicles, locomotive traction applications, industrial motors, and other variable torque applications that benefit from smart energy conversion.

Intellectual Property

Exro’s proprietary, patented software controls electric motor coils through individual coil switching. This introduction of intelligence into energy conversion at the level of individual coils results in expanded speed/torque capability, improved machine efficiency, reliability, safety and maintenance across a wider operating range. Exro’s advanced control algorithms create smart, real-time optimized power management.

Exro currently holds 15 patents, with 8 patents pending and additional patents under development. The company continues to expand its IP portfolio to support its goal of becoming a globally recognized leader in leveraging advanced control algorithms to improve the performance, efficiency and longevity of electric motors and generators.

Market Opportunity

Electric motors are the single biggest consumer of electricity. They account for about two-thirds of industrial power consumption and about 45% of global power consumption, according to an analysis by the International Energy Agency. Exro’s technology seeks to give industries a new way to look at energy—from electric vehicles, to industrial equipment, to renewable applications like wind farms; we are improving the way energy is consumed.

Laboratory Expansion

The 6,500-square-foot Exro Innovation Center (EIC), scheduled to open spring of 2020 in Calgary, will transition the current Victoria lab into one Calgary based center. The company’s new laboratory space will expand its service capabilities to customers, provide larger test capabilities, and showcase how Exro’s technology can be applied to dramatically improve the performance of electrical motors.

The EIC will also host collaborative events to explore advances in energy consumption and electric motor innovations, with participants from across Canada and around the world.

Strategic Partnerships

  • A strategic agreement with Finland’s Aurora Powertrains Oy, which in 2019 released an all-electric production snowmobile called the “eSled,” will see Exro’s technology added to the Aurora electric powertrain. The snowmobile sector’s economic footprint is estimated at $26 billion in the U.S., $8 billion in Canada, and $5 billion in Europe and Asia.
  • An agreement with Potencia in Mexico serving the last mile vehicle segment will integrate Exro’s custom drive and EPM module into small passenger commercial vehicles (taxis) and fleet delivery trucks
  • A licensing agreement with Motorino Electric, a leader in the Canadian electric transportation industry, will integrate Exro’s Electric Power Module technology into Motorino’s CTi electric bicycle.

Management

Chief Executive Officer Sue Ozdemir is a proven leader in the innovation and manufacturing of electric motors. She has nine years of accomplishments at General Electric, acting as CCO and the CEO of GE’s Small Industrial Motors Division, overseeing the division’s North American and international markets – ultimately building the division into a $160 million enterprise.

Chief Commercial Officer Josh Sobil is leading the seamless adoption of Exro’s growing product portfolio focused on the mobility segment and opening doors in all segments including agriculture, heavy industry, energy, construction, among others.

Executive Chairman Mark Godsy is a serial technology entrepreneur who has been involved in many top tier ventures, including two of Canada’s most successful biotech companies.

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), closed Wednesday's trading session at $0.669, up 10.5785%, on 339,909 volume with 165 trades. The average volume for the last 3 months is 400,223 and the stock's 52-week low/high is $0.133000001/$1.14999997.

Recent News

chart

iClick Interactive Asia Group Ltd. (NASDAQ: ICLK)

The QualityStocks Daily Newsletter would like to spotlight iClick Interactive Asia Group Ltd. (NASDAQ: ICLK).

iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, on Tuesday announced that its management team will give a company update and share their current views on the industry in a virtual Tech Talk hosted by Brian Kinstlinger, Head of Technology Research at Alliance Global Partners. iClick’s presentation is scheduled to begin at 10:00 a.m. Eastern Time on July 16, 2020. Interested parties may register for the Tech Talk by visiting the following link: http://nnw.fm/7UmxM. To view the full press release, visit http://nnw.fm/Hf2bu

iClick Interactive Asia Group Ltd. (NASDAQ: ICLK) is an independent online marketing and enterprise data solutions provider connecting worldwide marketers with audiences in China. Built on cutting-edge technologies, iClick’s proprietary platform possesses omni-channel marketing capabilities and fulfills various marketing objectives in a data-driven and automated manner, helping international and domestic marketers reach their target audiences. Headquartered in Hong Kong, iClick operates in 10 locations worldwide, including Asia and Europe.

iClick aims to become a fully integrated Enterprise and Marketing Cloud Platform in China, providing clients a full consumer-cycle solution. This is facilitated by two pillars’ growth strategy through two business segments: Marketing Solutions and Enterprise Solutions.

Marketing Solutions

Using data and AI-driven technology to help brands efficiently identify, target and acquire the right customers

As the leading programmatic marketing platform in China, iClick’s proprietary platform collects a wealth of data from multiple sources to precisely reach the right audience at the right moment, on the right channel and right device. Cross-screen search solutions capture critical micro-moments when users proactively search for what they need. This multi-dimensional approach to marketing allows iClick to effectively understand internet users and exponentially widen target audiences for its brand clients. Multiple monetization models available in the Marketing Solutions segment allow iClick to serve its clients in several ways, such as audience targeting.

Data-driven marketing is indispensable to marketers targeting specific audiences in China. More than 825 million internet users in China are anonymously profiled on iClick’s platform, which boasts cross-channel and cross-screen capabilities.

Enterprise Solutions

Enabling brands to efficiently manage their consumers through online and offline data integration and analysis, increase the repurchase rate, and enhance consumers’ loyalty

iClick’s Enterprise Solutions segment addresses enterprise needs in China, particularly focusing on “smart retail,” an expanding and innovating market involving the combination of online and offline consumers’ behavioral information. Enterprise Solutions support detailed profiling of customers, which facilitates data-driven business strategies, enhances business processes at various levels, and increases operational and marketing efficiency.

Enterprise Solutions leverages iClick’s proprietary platform that incorporates Artificial Intelligence (AI) to learn, build and store knowledge, enabling accurate predictions about consumer behavior that ultimately provide marketing solutions derived from the large amount of available data.

Through a strategic partnership with Tencent, iClick’s Enterprise Solutions presents strong recurring revenue streams with tremendous opportunities to upsell multi-national corporations (MNCs). Tencent’s proprietary API connection enables brands to build 360-degree consumer profiles based on the collection and integration of purchased behavioral information from online and offline touchpoints, including WeChat Mini Programs, WeChat Payment, WeChat Work and more.

As iClick continues to provide integrated marketing and smart retail solutions targeting Chinese consumers, the company believes Enterprise Solutions has strong long-term growth potential and will become a major gross margin contributor in the future.

Partnerships

In 2019, iClick established various agreements and partnerships with a number of leading southeast and northeast Asian companies for regional diversification and in 2020 is focused on continuing to develop additional partnerships and new business models globally. Many of the world’s top companies are leveraging iClick’s proprietary data platform to precisely identify and reach out to core target audience groups in China.

The company’s partnerships include:

  • A tri-partnership with BTG WELINK, an online retail services arm of Beijing Tourism Group (“BTG”), and Tencent Holdings Ltd., China’s leading provider of internet value added services. As part of this partnership, iClick applies its upgraded solutions to build a private DSP (Demand Side Platform) system for BTG. Using Tencent’s big data advertising platform, iClick can assist BTG to develop precision marketing campaigns.
  • An Advertising Agency Authorization Certificate from Baidu Inc. (NASDAQ: BIDU), under which iClick is designated the authorized agency for native advertising of Baidu’s news feed ads. Native advertising is a consumer-friendly, non-disruptive advertising format that has gained rapid popularity among advertisers in recent years. Native advertising and creative marketing content have become a more effective marketing method among the Chinese young consumers. In 2019, the native advertising sector was estimated to have an around 53.5% share of the online advertising revenue, according to Statista.
  • A joint-venture partnership with VGI Global Media Plc (VGI.BKK), Thailand’s No. 1 online to offline (O2O) solutions provider across advertising, payment and logistics platforms, which enables brands in Southeast Asia to capture the multi-billion-dollar Chinese consumer market through a range of technology-driven marketing solutions.

Case Study: Armani Hotel Dubai

Dubai has been gearing up to welcome the growing wave of Chinese visitors. Chinese nationals are eligible for a 30-day visa-on-arrival into the UAE, which gives Chinese travelers tremendous convenience. In light of this, Armani Hotel Dubai set the objective to increase its sales in this market.

The challenge: What Aarmani Hotel Dubai lacked in executing this goal was insightful understanding of Chinese travelers in particular the demographics that were likely to be attracted to the hotel. Challenged by the huge differences in the business practice, unique culture and language barrier in running digital campaigns in China, Armani Hotel Dubai turned to iClick’s know-how and expertise to guide its campaign to success and meet its sales goal.

The solution: iClick tailored an optimal solution for the hotel to increase brand awareness and booking rate from China – which is the key market for the hotel – and successfully assisted Armani Hotel Dubai in reaching its target Chinese audiences by using China’s most popular mobile and internet sites, including WeChat and Weibo, to improve reach and booking potential.

The results: Due to iClick’s unrivaled technological and execution strengths, Armani Hotel Dubai’s ads were delivered in an omnichannel manner, raising brand awareness and garnering interest between Chinese consumers. Subsequently, Armani Hotel Dubai saw a surge in conversion rate.
During the campaign, the Armani Hotel Dubai brand was connected with 87% of Chinese mobile users.

Award-winning Provider

iClick, a Deloitte Technology Fast50, has received multiple industry awards from the international marketing community. The company is committed to helping clients access digital China with its omni-channel, data-driven marketing solutions that deliver uniquely sharpened marketing capabilities and outstanding advertising results.

Most recently, iClick subsidiary OptAim (Beijing) Information Technology Co., Ltd was recognized by Tencent Ads as a 2019 Gold Service Provider. Tencent Ads also named OptAim the winner of three major annual awards for the second half of 2019: “Outstanding Contribution of the Year,” “Best Technology & Data Application Award,” and “Best Branding Awards.”

In November 2019, company co-founder and CEO Sammy Hsieh was chosen as the winner of the “EY Entrepreneur of The Year China 2019 Award in Technology Category,” an award recognizing his entrepreneurial acumen, innovative spirit and strong leadership. As one of the world’s most prestigious business accolades, the “EY Entrepreneur of The Year” awards program honors those who accomplish success by combining ability with opportunity, and inspire others with great vision, leadership and outstanding achievement.

iClick won the Annual Influential Platform Award and the Innovation Golden Award in Marketing at the Creative Award 2019, as well as the Best Tourism Marketing Agency. The company was also the recipient of the “Best Brand and Performance Marketing Award” at the Performance Marketing Ecosystem Summit 2018 hosted by the Advertising & Marketing Service, a division of Tencent Holdings Limited.

The company in 2018 was also recognized as “Platinum Service Partner of Tencent Social Ads” at the Tencent Key Accounts Mid-Year Summit held in Beijing. The mobile division of iClick, Optaim, received the same award beginning in 2016. Optaim was also the “Best DSP Partner” and “Key Account Data Partner” of Tencent, making it the only player in China with such unique and deep level of cooperation with Tencent Social Ads.

Leadership

Sammy Wing Hong Hsieh, chairman of the board and co-founder, was CEO from 2009 to 2019. Prior to co-founding iClick, Hsieh held senior positions in several prominent technology companies. He was general manager for Asia Pacific at Efficient Frontier (now an Adobe company), a leading digital performance marketing company, and was director of Search Marketing at Yahoo Hong Kong from 2000-2008. Hsieh received a bachelor’s degree in economics from the University of California, Los Angeles.

Jian Tang, director, CEO and co-founder, has 20 years of experience in digital advertising and is well-known in China for his expertise in advertising technologies and big data. In 2012, he founded OptAim, which was acquired by iClick in 2015, and has served key research, engineering and management roles at Yahoo’s global research and development center. Tang received his doctorate in computer engineering from Tsinghua University and was named by Campaign Asia as one of the leaders in its Digital A-List in 2016.

Terence Chi Wai Li, chief financial officer, has 15 years of experience in financial management, investment and business operations. He has served in management roles and advisory capacities at several start-ups, in addition to financial management and fundraising roles. He previously worked at PricewaterhouseCoopers, specializing in M&A due diligence and cross border tax and deal structuring projects. Li received an MBA from Oxford University’s Said Business School. He is a Fellow Member of ACCA, a Member of HKICPA, and a Chartered Financial Analyst.

iClick Interactive Asia Group Ltd. (NASDAQ: ICLK), closed Wednesday's trading session at $5.43, up 2.4528%, on 481,341 volume with 2,740 trades. The average volume for the last 3 months is 525,519 and the stock's 52-week low/high is $2.73000001/$5.98999977.

Recent News

chart

Jerrick Media Holdings, Inc. (OTC: JMDA)

The QualityStocks Daily Newsletter would like to spotlight Jerrick Media Holdings, Inc. (OTC: JMDA).

Jerrick Media Holdings (OTCQB: JMDA), a technology company and the parent company of Vocal and Creatd, is being called an “industry-disrupting unicorn” in an article on SeekingAlpha.com authored by Sergio Heiber noting that the company has a diversified revenue stream plan, including subscriptions and services, along with a low-maintenance, scalable, technology platform that allows for quickly attaining profitability. To view the full article, visit http://nnw.fm/mZdR7

Jerrick Media Holdings, Inc. (OTC: JMDA) develops technology-based solutions to solve digital problems. Through the combination of design, thought and data analysis, the company builds products that influence a worldwide audience.

Jerrick’s flagship product is Vocal, a proprietary long-form digital publishing platform that provides storytelling tools and engaged communities for creators to get discovered and fund their creativity.

Vocal

Designed to develop and cost-effectively engage content creators, the Vocal platform enables its over 500,000 registered content creators to reach an engaged audience and monetize their content. In addition to providing relevant content, Vocal’s technology is centered on efficiency and scalability through its niche digital communities, as well as output through its data-driven distribution strategy.

Vocal partners with content creators and brands that recognize difficulties inherent in the digital advertising space and that can benefit from branded content marketing opportunities available on publishing platforms like Vocal.

All content available on Vocal is created within the platform’s custom editor and published on one of Vocal’s embedded genre-specific communities, spanning topics that range from food to wellness, beauty, technology and more.

In May 2019, Jerrick launched Vocal+, its premium subscription membership program. Vocal+ members pay a membership fee for premium value-added features, including receiving increased earnings for their content, reduced platform processing fees for tips received, a Vocal+ badge on their creator page, access to new features on the Vocal Platform, and other rewards. Creators can sign up for free or upgrade to Vocal+, available for purchase on either an annual or monthly subscription basis.

 

Vocal for Brands

Vocal for Brands is an in-house creative studio that generates actionable data from bespoke native advertising campaigns. Vocal for Brands partners with direct-to-consumer (DTC) to create beautiful, campaign-optimized stories on Vocal that build brand affinity, trust and drive results.

Additionally, Jerrick provides a Managed Services offering to business-to-business (B2B) and business-to-consumer (B2C) product and service brands which encompasses a full range of digital marketing and e-commerce solutions. Managed Services includes the setup and ongoing maintenance of clients’ websites, Amazon and Shopify storefronts and listings, social media pages, search engine marketing, and other various tools and sales channels utilized by e-commerce sellers for sales and growth optimization. In addition to partnering with Managed Services clients, the company offers a range of la carte services.

Growth Strategy

Upon the consummation of its anticipated listing on the Nasdaq Capital Market, Jerrick intends to change its official company name to “Creatd, Inc.,” subject to stockholder approval.

This rebranding will initiate Jerrick’s go-forward growth strategy and its plans to expand its offerings and provide technology products and resources for creators to help transform their ideas into reality. The strategic plan is designed to greatly increase Jerrick’s potential market value via a plethora of new revenue streams.

Creatd will focus on a community of creators that number more than 2.5 billion users, for which it will offer democratized, transparent platforms for distribution, sentiment, resources and monetization. The company’s agile development process will rely on a combination of bleeding-edge technology that eliminates barriers and creates efficiencies. Superior design thinking and data analysis will allow Creatd to expand its digital footprint to a global community.

Creatd will partner with a community of technology collaborators and sophisticated investors who collaborate to provide technology solutions for creators, brands and their respective audiences. The company’s solutions, business processes, technology platforms and design theories will lend themselves to application opportunities on a global scale.

History & Management

Jerrick was founded in 2012. Initially a private media company providing online content through a portfolio of brands, Jerrick’s needs quickly outpaced its initial technology and product offering. In 2015, Jerrick partnered with Thinkmill, a premiere, Australia-based product design and development group to create a content management system (CMS) for its brands; that system evolved into the company’s flagship product, Vocal.

Today, Jerrick’s management team is an impressive group of abstract thinkers united by their passion to solve problems. Leading the team are founder and CEO Jeremy Frommer, and Justin Maury, Jerrick’s president and head of product.

Frommer’s career includes two decades in the financial technology industry, working as a hedge fund and portfolio manager, as well as on the sell-side of the financial industry. Frommer started NextGen Trading, a software development company building proprietary equity trading platforms. NextGen was acquired by Carlin Financial Group of which Frommer became CEO. RBC Capital Markets Corporation eventually bought Carlin. At RBC, Frommer was managing director, head of the Global Prime Services group and a member of the RBC Global Equities Operating Committee.

Maury joined Jerrick in 2013, bringing with him 10 years of experience in the creative industry. Since partnering with Frommer to establish Jerrick, Maury led the company’s product development for more than four years. His passion for the creative arts and technology ultimately yielded the vision for Vocal. During the Jerrick’s early formative years, Maury was a driving force in creating the vision, design and architecture for the Vocal platform and managing the oversight of technology development.

Jerrick Media Holdings, Inc. (JMDA), closed Wednesday's trading session at $5.25, up 2.9412%, on 13,300 volume with 20 trades. The average volume for the last 3 months is 4,063 and the stock's 52-week low/high is $2.15000009/$6.46999979.

Recent News

chart

Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF)

The QualityStocks Daily Newsletter would like to spotlight Standard Lithium Ltd. (OTC: STLHF).

Standard Lithium (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF), an innovative technology and lithium development company, today provided updates regarding its two operational pilot plant projects. To view the full press release, visit http://nnw.fm/4S0qe.

Standard Lithium Ltd. (OTC: STLHF) is focused on unlocking the value of existing large-scale U.S.-based lithium brine resources that can quickly be brought into production. The Company believes new lithium production can rapidly be brought on stream by minimizing project risks at selection stage; resource, political & geographic, and regulatory & permitting; and by leveraging advances in lithium extraction technologies and processes.

The Company’s flagship project is in southern Arkansas. The more than 180,000-acre “Smackover Project” is in the most prolific and productive brine processing region in North America. Agreements with large commercial brine operators in the region will allow Standard Lithium to utilize the extensive existing infrastructure, including brine supply and disposal pipelines, water, power and a trained workforce to fast-track project development timelines.

“Arkansas produces about 9.4 billion gallons of brine per year, according to 2010-2016 average statistics reported by the Arkansas Oil & Gas Commission.”

Standard Lithium signed a binding MoU with global specialty chemicals company LANXESS Corporation and its U.S. affiliate Great Lakes Chemical Corporation with the purpose of demonstrating the commercial viability of extraction of lithium from brine (“tail brine”) that is produced as part of LANXESS’ bromine extraction business at its three Southern Arkansas facilities.

LANXESS’ land operations in Southern Arkansas encompass more than 150,000 acres, 10,000 brine leases and surface agreements and 250 miles of pipelines. LANXESS extracts the brine from its wells located throughout the area, and the brine is transported to the three Arkansas plants through a network of pipelines. The three bromine extraction plants currently employ approximately 500 people and process and reinject several hundred thousand barrels of brine per day.

Standard Lithium has developed a breakthrough rapid lithium extraction process that reduces the recovery time of extracting lithium from brine to as little as several hours vs. the current industry method that takes years. The process is also much more environmentally friendly with a significantly smaller footprint than the conventional processes. The company has a signed agreement to locate a demonstration scale lithium extraction plant inside one of LANXESS’ chemical plants in Southern Arkansas.

The Company has also signed an option agreement with NYSE-listed Tetra Technologies for the lithium rights for exploration, extraction, and possible commercial development on approximately 30,000 acres of brine leases in Southern Arkansas. The largest available land package.

Recent laboratory results of four brine samples recovered from two existing wells in Standard Lithium’s project area showed lithium concentrations ranging between 347-461 mg/L lithium, with an average of 450 mg/L lithium in one of the wells and 350 mg/L in the other. Geological modeling of the project area is complete, and a maiden resource report is on the horizon.

Market Opportunity

World demand for lithium continues to surge. The global lithium compounds market is projected to reach U.S. $5.87 billion by 2020 at a compound annual growth rate of 13.22% between 2015 and 2020. Lithium-ion batteries are the fastest growing segment of the market.

Leadership

Standard Lithium’s commitment to being a premier, innovation-driven company focused on developing and commercializing new modern processes for lithium extraction is bolstered by the leading experts that comprise the company’s Scientific Advisory Council. Each member was selected because of their experience and expertise in areas that are central to and/or complement Standard Lithium’s current development plans. Standard Lithium recently welcomed to the Council world-renowned chemist Dr. Barry Sharpless, the recipient of the 2001 Nobel Prize in Chemistry for his work on chirally catalyzed oxidation reactions.

Standard Lithium is led by a team of professionals with proven strong technical and project development skills. CEO Robert Mintak has a global network of industry contacts and is a pioneer in the rapidly evolving lithium space. COO and President Dr. Andy Robinson is an experienced geoscientist with 20+ years of experience and a PhD in Geochemistry from the University of Bristol, UK. Dr. Robinson has worked on a wide range of projects in the resource, power and energy sectors in Europe, Africa, and North and South America.

The company recently appointed Robert Cross as non-executive chairman. Cross is an engineer with 25 years of experience as a financier and company builder in the mining and oil and gas sectors. He co-founded and serves as chairman of B2Gold, a top-performing growing gold producer which is expected to achieve nearly 1 million ounces of low-cost gold production in 2018. He was also co-founder and chairman of Bankers Petroleum Ltd.; co-founder and chairman of Petrodorado Energy Ltd.; and until October 2007 was the non-executive chairman of Northern Orion Resources Inc. He also was previously the chairman and CEO of Yorkton Securities Inc., and a partner in investment banking with Gordon Capital Corp. in Toronto. Cross has an engineering degree from the University of Waterloo (1982) and received an MBA from Harvard in 1987.

Following a multi-million-dollar financing in Q1 2018, Standard Lithium is well-positioned to meet its upcoming milestones including two maiden resource reports and the launch of its breakthrough rapid lithium extraction technology.

Standard Lithium Ltd. (OTC: STLHF), closed Wednesday's trading session at $0.8772, up 3.8721%, on 59,667 volume with 80 trades. The average volume for the last 3 months is 80,722 and the stock's 52-week low/high is $0.29519999/$1.14999997.

Recent News

chart

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex Inc. (NASDAQ: GNPX) was featured today in a publication from BioMedWire, examining how, when the coronavirus pandemic reached the U.S., the FDA reacted swiftly to come up with quick solutions. In a few weeks, emergency testing was already in place, and that was an opportunity to convert some of the machines to be used as ventilators. The pandemic has paved the way for some new changes and trends, and they are going to have a significant impact on the medical industry.

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed Wednesday's trading session at $3.085, up 4.223%, on 1,185,446 volume with 2,730 trades. The average volume for the last 3 months is 2,660,979 and the stock's 52-week low/high is $0.231000006/$7.0300002.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.